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Nuclear pore protein NUP210 depletion suppresses
metastasis through heterochromatin-mediated
disruption of tumor cell mechanical response
Ruhul Amin 1✉, Anjali Shukla1, Jacqueline Jufen Zhu 2, Sohyoung Kim 3, Ping Wang2,
Simon Zhongyuan Tian2, Andy D. Tran 1,4, Debasish Paul1, Steven D. Cappell 1, Sandra Burkett 5,
Huaitian Liu1,6, Maxwell P. Lee 1,6, Michael J. Kruhlak1,4, Jennifer E. Dwyer7, R. Mark Simpson7,
Gordon L. Hager 3, Yijun Ruan2 & Kent W. Hunter 1✉
Mechanical signals from the extracellular microenvironment have been implicated in tumor
and metastatic progression. Here, we identify nucleoporin NUP210 as a metastasis sus-
ceptibility gene for human estrogen receptor positive (ER+) breast cancer and a cellular
mechanosensor. Nup210 depletion suppresses lung metastasis in mouse models of breast
cancer. Mechanistically, NUP210 interacts with LINC complex protein SUN2 which connects
the nucleus to the cytoskeleton. In addition, the NUP210/SUN2 complex interacts with
chromatin via the short isoform of BRD4 and histone H3.1/H3.2 at the nuclear periphery. In
Nup210 knockout cells, mechanosensitive genes accumulate H3K27me3 heterochromatin
modification, mediated by the polycomb repressive complex 2 and differentially reposition
within the nucleus. Transcriptional repression in Nup210 knockout cells results in defective
mechanotransduction and focal adhesion necessary for their metastatic capacity. Our study
provides an important role of nuclear pore protein in cellular mechanosensation and
metastasis.
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The majority of cancer-related mortality is due to distantmetastasis, a process in which primary tumor cells invadeinto surrounding endothelium, evade immunosurveillance
in the circulation, travel to a distant site, extravasate, and colonize
a secondary site1–3. This highly inefficient process requires cancer
cells to employ multiple genetic and epigenetic mechanisms to
establish macroscopic lesions. However, due to the limited
understanding of these mechanisms, it is difficult to target meta-
static cells, even with the improved therapeutic strategies4. Hence,
an improved understanding of the mechanisms that enable
metastatic potential is crucial to improve patient outcomes.
Current studies have suggested that metastatic capacity in
tumors may arise from the combined effect of acquired somatic
mutations5 and epigenetic changes influencing gene expression6,7.
Changes in chromatin accessibility8 or disruptions of large het-
erochromatin domains9 can result in alteration of transcriptional
programs that enable tumor cells to acquire metastatic pheno-
types. In addition to these changes, previously our laboratory has
demonstrated that inherited polymorphisms also have a sig-
nificant effect on metastatic capacity10. Since the vast majority of
inherited polymorphisms occur in noncoding DNA, these
inherited variants are thought to contribute to phenotypes by
altering gene expression rather than having direct consequences
on protein function. A comprehensive understanding of how the
genome mediates metastatic capacity will therefore require an
understanding of not only the acquired events during tumor
evolution but also how noncoding variants contribute to the
complexities of gene regulation and transcriptional programs.
To gain further understanding of how polymorphisms affect
regulatory elements and the subsequent metastatic phenotype, in
this study, we have integrated chromatin accessibility and long-
range chromatin interaction analysis to identify potential
metastasis susceptibility genes with polymorphic promoters and/
or distant enhancers. This analysis identified Nup210, a gene
encoding a nuclear pore complex (NPC) protein, as a potential
metastasis susceptibility gene. Although NPC proteins have
recently been shown to be associated with several developmental
disorders and cancers11–14, their function in metastasis remains
unexplored. Here, we established that NUP210 is responsive to
mechanical signals of the extracellular microenvironment and
promotes lung metastasis in mouse models of breast cancer
through alteration of the mechanical response, focal adhesion,
and cell migration in a nucleocytoplasmic transport-independent
manner.
Results
Identification of Nup210 as a candidate metastasis suscept-
ibility gene. To identify polymorphic accessible chromatin
regions associated with metastatic colonization, benzonase-
accessible chromatin (BACh) analysis was performed on iso-
genic cell lines derived from the spontaneous mammary tumor of
BALB/cJ mice (67NR, 4T07, and 4T1)15 (Fig. 1a). When ortho-
topically implanted into mice, 67NR forms tumors but remains
localized, 4T07 cells disseminate to distant sites but rarely form
macroscopic lesions, while 4T1 cells complete the metastatic
process to form multiple pulmonary macroscopic lesions.
To identify transcriptional control regions enriched for the
dormant-to-proliferative switch during metastatic colonization,
5303 BACh sites unique to the 4T1 cell line were identified. These
sites were then intersected with the polymorphisms present in the
eight founder strains16 of the mouse Diversity Outbred (DO)
genetic mapping panel17. Since the vast majority of these sites did
not fall within the proximal promoters of protein-coding genes,
chromatin interaction analysis through paired-end tag sequen-
cing (ChIA-PET-seq) was performed in 4T1 cells to putatively
link the polymorphic transcriptional control elements (promoters
and/or enhancers). Finally, the resulting gene list was filtered
through expression data of mice resulting from a cross between
the MMTV-PyMT model18 and the DO to identify genes
associated with metastasis in this population. This strategy
identified 52 potential metastasis susceptibility genes (Fig. 1b). To
assess human relevance, the hazard ratios calculated for these
genes in the mouse data were used to generate a weighted gene
signature that was subsequently screened on human breast cancer
gene expression datasets. Significant stratification of distant
metastasis-free survival (DMFS) in estrogen receptor-positive
(ER+) breast cancer was observed (Fig. 1c), consistent with a
potential role of these genes in human breast cancer progression.
NUP210, a nuclear pore protein, was selected for further
validation due to the association of a number of previously
identified metastasis susceptibility genes with the nuclear
envelope19. To test the function of Nup210 in metastasis, we
initially asked whether variation in Nup210 expression would
correlate with metastatic potential. Our RNA-sequencing (RNA-
seq) data from the 4T1 series of cell lines revealed that Nup210
expression is higher in metastatic than nonmetastatic variant cell
lines (Fig. 1d) suggesting a positive correlation of Nup210
expression and metastatic potential.
Polymorphisms in the Nup210 promoter affect CTCF binding
and Nup210 transcription. To examine the causal variant
responsible for the transcriptional difference in the mouse genetic
screen, the proximal promoter of Nup210 was identified based on
the BACh profile (Fig. 1e). Analysis of the Mouse Genomes
Project database16 revealed six single-nucleotide polymorphisms
(SNPs) and one insertion/deletion (indel) in a 510 bp promoter
region of Nup210 (Fig. 1f). This included a 12 bp G-rich insertion
in the Nup210 promoter of the FVB/NJ, the MMTV-PyMT
parental strain (Fig. 1g), located within a CCCTC-binding factor
(CTCF)-binding region enriched in enhancer (H3K27Ac)-pro-
moter (H3K4me3) marks20. CTCF binding on Nup210 promoter
also appeared to be evolutionarily conserved between mouse and
human based on the analysis in MCF7 human breast cancer cell
line (Fig. 1h). We initially tested whether the polymorphisms
within Nup210 promoters can affect gene expression via cloning
these 510 bp regions into a promoter-luciferase reporter. A
moderate (~10%), but significant, reduction of luciferase activity
was observed for the FVB/NJ-derived Nup210 promoter region
compared to the BALB/cJ promoter indicating a functional
impact of the polymorphism on Nup210 transcription (Fig. 1i).
Then, we examined the effect of 12 bp indel on CTCF binding
and Nup210 transcription as CTCF is known to regulate gene
expression21,22. CTCF was preferentially enriched in the Nup210
promoter region of 4T1 cells (derived from BALB/cJ mice)
compared with 6DT1 cells (derived from FVB/NJ mice) (Fig. 1j).
Consistently, the expression of Nup210 and Ctcf were significantly
higher in 4T1 cells than in 6DT1 cells (Fig. 1k). In addition,
Nup210 expression was significantly lower in the normal spleen of
FVB/NJ compared to BALB/cJ mice (Fig. 1l) despite similar levels
of Ctcf. CRISPR/Cas9-mediated deletion of CTCF-binding site on
4T1 Nup210 polymorphic promoter showed significantly
decreased Nup210 mRNA, which further supported that Nup210
promoter indel is a direct target of CTCF (Fig. 1m and Supple-
mentary Fig. 1a–c). Ctcf mRNA was also downregulated in these
deletion clones indicating a potential positive feedback loop
between NUP210 and CTCF. Furthermore, Ctcf knockdown in
4T1 cells revealed a marked reduction of Nup210 both at the
transcript (Fig. 1n) and protein level (Fig. 1o), suggesting a direct
effect of CTCF loss on Nup210 transcription. Taken together,
these results suggest that Nup210 is a CTCF-regulated gene and
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the indel in the promoter alters Nup210 transcription by mod-
ulating CTCF binding to the promoter region.
NUP210 expression is associated with metastasis in human
breast cancer patients. Consistent with the mouse data, NUP210
amplification in human breast cancer patients was found to be
associated with decreased overall survival in the Molecular
Taxonomy of Breast Cancer International Consortium (METAB-
RIC) dataset23 (Fig. 2a). Two independent human breast cancer
gene expression datasets suggested that NUP210 mRNA expression
was significantly associated with reduced overall survival (Fig. 2b,
METABRIC) and DMFS (Fig. 2c, Km plotter)24 in estrogen
receptor-positive (ER+) breast cancer patients. However, the
patient survival outcome appears to be moderate in these datasets,
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suggesting that NUP210 expression is likely one of the multiple
factors contributing to the patient outcome. Although the associa-
tion of NUP210 mRNA expression among triple-negative (ER−/PR
−/HER2−) breast cancer patients were not consistently significant
in these two datasets (Supplementary Fig. 2a, b), recent proteomics
analysis revealed that higher NUP210 protein level is significantly
associated with the poor DMFS of triple-negative cancer patient
(Km plotter) (Supplementary Fig. 2c)25. METABRIC data suggest
that NUP210 expression is higher in luminal B and basal subtypes
than in luminal A, Her2+, and claudin-low subtypes of breast
cancer (Fig. 2d). Consistently, immunohistochemical analysis in the
human normal mammary gland revealed that NUP210 is pre-
dominantly expressed in the luminal cell compartment (Fig. 2e).
Analysis of a small human breast cancer tissue microarray (TMA)
revealed that the NUP210 protein level was heterogeneous among
the primary tumors of both ER+ and ER− patients (Fig. 2f).
Interestingly, in addition to nuclear envelope staining of NUP210,
cytoplasmic staining was also observed in many cases suggesting
that NUP210 might be mislocalized in some patients. Confining the
quantification of NUP210 signal intensity at the nuclear envelope
revealed no significant difference between ER+ and ER− primary
tumors (Fig. 2g). However, the NUP210 level was significantly
higher in the lymph node metastases of ER+ than ER− patients
(Fig. 2h, i), consistent with the survival outcome of the breast cancer
patient in different datasets. Analysis in publicly available gene
expression data of breast cancer patients revealed that visceral
metastases (lung, liver) have significantly higher expression of
NUP210 than nonvisceral metastases (lymph node) (Fig. 2j). Fur-
thermore, NUP210 expression is significantly higher in metastases
than primary tumor of prostate cancer (Supplementary Fig. 2d) and
melanoma (Supplementary Fig. 2e). These data indicate that
NUP210 is associated with human cancer progression and further
supports its potential role as a metastasis susceptibility gene.
Depletion of Nup210 in cancer cells decreases lung metastasis
in mice. To validate the role of Nup210 in metastasis, luminal-like
orthotopic mammary tumor transplantation models were used26.
Three different cell lines were utilized for this analysis: 4T115,
6DT1, derived from the mammary tumor of FVB/MMTV-MYC
transgenic mouse, and MVT1, derived from the mammary tumor
of FVB/MMTV-MYC/VEGF double transgenic mouse27. Primary
tumors derived from orthotopically implanted Nup210 short
hairpin RNA knockdown (Fig. 3a and Supplementary Fig. 3a)
cells showed variability in tumor weight, with decreased tumor
weight for 4T1 cells (Fig. 3b), but increased tumor weights for
both 6DT1 and MVT1 cells (Supplementary Fig. 3b). However,
Nup210 knockdown resulted in a decrease in pulmonary metas-
tases for all three cell lines (Fig. 3c, d and Supplementary
Fig. 3c–f), and this decrease was preserved after normalizing
metastasis counts by tumor weight to account for the variability
in primary tumor growth. These results were therefore consistent
with the association of NUP210 with poor prognosis in patients
with ER+ breast cancers.
To further validate the role of Nup210 in metastatic
progression, CRISPR/Cas9-mediated knockout (KO) of Nup210
was performed in the 4T1 cell line (Fig. 3e). Similar to short
hairpin RNA (shRNA) result, Nup210 KO in two different clones,
N9 and N13, diminished primary tumor weight and lung
metastases (Fig. 3f–h). Although we observed differential effects
of Nup210 loss on primary tumor weight, cell cycle analysis on
Nup210 KO 4T1 cells (Fig. 3i, j) revealed no consistent changes in
the distribution of cell population among cell cycle stages,
suggesting that the effect of NUP210 loss on tumor and
metastasis is independent of a cell-intrinsic ability of NUP210
to regulate proliferation. Finally, 4T1 cells with overexpression of
Nup210 showed no difference in primary tumor weight (Fig. 3k,
l), but lung metastasis was significantly increased (Fig. 3m, n).
Taken together, these results indicate that Nup210 promotes lung
metastasis in mouse models of luminal breast cancer.
NUP210 tethers histone H3.1/3.2 to the nuclear periphery. To
investigate the mechanism by which NUP210 alters metastatic
function, initially we examined the effect of NUP210 depletion on
nucleocytoplasmic transport, a general function of the nuclear
pore. A recent study has suggested that loss of NUP210 does not
affect the general nucleocytoplasmic transport in differentiating
myotubes28. Consistent with this, transfection of NES-tdTomato-
NLS nucleocytoplasmic transport reporter (Supplementary
Fig. 4a) into Nup210 knockdown 4T1 cells with or without the
nuclear export inhibitor leptomycin B showed no significant
differences in nucleocytoplasmic transport of the reporter protein
(Supplementary Fig. 4b).
To better understand how NUP210 promotes metastasis,
NUP210 coimmunoprecipitation (Co-IP)-mass spectrometry
analysis was performed (Fig. 4a). Both endogenous and myc-
tagged NUP210 potentially interact with multiple chromatin-
associated molecules including histone H3.1 (Fig. 4b). We
decided to examine NUP210–histone H3.1 interaction due to
the potential association of H3.1 with poor outcome in breast
cancer patients (P= 0.0642) in METABRIC dataset (Fig. 4c) and
reported mutations of histone H3.1 in human cancer29,30.
Reciprocal Co-IP in 4T1 cells using an antibody that recognizes
both H3.1 and H3.2 validated the predicted H3.1–NUP210
interaction (Fig. 4d, e). H3.1/3.2 also pulled down Lamin B1, a
component of the nuclear lamina, suggesting that this interaction
occurs at the nuclear periphery. Reciprocal co-IP using both
endogenous and Flag-tagged H3.1 in human 293FT cells also
showed a similar result (Fig. 4f). Immunofluorescence analysis
confirmed the association of H3.1/3.2 and NUP210 at the nuclear
periphery (Fig. 4g). Extending the analysis in human breast
cancer cells revealed that NUP210–H3.1/3.2 interaction is more
prominent in ER+ MCF7 cells than ER− MDA-MB-231 cells
Fig. 1 Genome-wide analysis of noncoding region polymorphisms identifies Nup210 as a metastasis susceptibility gene. a Scheme for metastasis
susceptibility gene identification. b Circos plot representation of the result in (a). Red lines= polymorphic promoter, blue lines= intrachromosomal, and
light blue lines= interchromosomal looping interactions. c Distant metastasis-free survival (DMFS) of human ER+ breast cancer patients stratified by their
expression of the 52-gene signature. Kaplan–Meier analysis with the log-rank test. d Nup210 mRNA expression in the mouse 4T1 cell line series. e
Integrative Genomics Viewer (IGV) track of the Nup210 promoter BACh region in 4T07 and 4T1 cells. f Polymorphisms within the 510 bp Nup210 promoter
region. g 12 bp FVB/NJ promoter indel is located within a CTCF-binding site in mouse Nup210 promoter. h CTCF and H3K27Ac enrichment in human
NUP210 promoter of MCF7 cells. i Luciferase assay of BALB/cJ and FVB/NJ Nup210 promoter regions. ANOVA, Tukey’s multiple comparison test,
mean ± s.e.m, n= 8 biological replicates. j ChIP analysis of CTCF and H3K27Ac at Nup210 promoter of 4T1 and 6DT1 cells. k Nup210 and Ctcf mRNA levels
in cell lines (4T1, 6DT1). Two-tailed t test, mean ± s.e.m, n= 3 biological replicates. l Nup210 and Ctcf mRNA levels in mouse spleen (BALB/cJ or FVB/NJ).
Two-tailed t test, mean ± s.e.m, n= 5 mice. m Nup210 and Ctcf mRNA level in Nup210 promoter CTCF-binding site-deleted clones. Two-tailed t test,
mean ± s.e.m, n= 3 biological replicates. n Effect of Ctcf knockdown on 4T1 Nup210mRNA levels. Two-tailed t test, mean ± s.e.m, n= 3 biological replicates.
o Effect of Ctcf knockdown on NUP210 protein level in 4T1 cells.
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(Supplementary Fig. 5a, b). These results establish an evolutio-
narily conserved association of NUP210 with H3.1/3.2 in mouse
and human cells.
Increased recruitment of heterochromatin-modifying enzymes,
SUV39H1 and EZH2, to H3.1/3.2 in Nup210 KO cells. H3.1 is
known to be incorporated into nucleosomes in the S phase of the cell
cycle in a replication-dependent manner31, which suggested that
NUP210 loss might affect S-phase progression. As mentioned ear-
lier, there were no consistent changes in the S phase of the cell cycle
in Nup210 KO cells (Fig. 3i, j), suggesting that NUP210–H3.1/3.2
association might have a different role in metastatic cells. The effect
of NUP210 loss on H3.1/3.2 interactions in metastatic cells was
therefore examined. Loss of NUP210 resulted in a redistribution of
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nucleus (Fig. 4h, i), suggesting that NUP210 might be tethering
H3.1/3.2 to the nuclear envelope. A significant enrichment of the
H3K27me3 heterochromatin mark at the nuclear periphery was also
observed. Costaining with H3K9me3, a pericentric heterochromatin-
associated histone marker, and 4′,6-diamidino-2-phenylindole
(DAPI) revealed that the redistributed H3.1/3.2 colocalized with
heterochromatin in Nup210 KO cells (Fig. 4j, k). 3D reconstruction
revealed that H3.1/3.2 foci were localized on the periphery of
H3K9me3-marked region (Fig. 4l and Supplementary Movies 1 and
2). Many of the foci appeared on the heterochromatin-enriched
nucleolar periphery (Fig. 4m). Like 4T1, H3.1/3.2 was also redis-
tributed from the nuclear periphery to intranuclear foci in NUP210-
depleted ER+ MCF7 cells (Supplementary Fig. 5c, d). Although
there was a significant loss of H3.1/3.2 from the nuclear periphery of
NUP210-depleted, ER−, MDA-MB-231 cells (Supplementary
Fig. 5e, f), H3.1/3.2 foci was not prominent in these cells suggesting a
subtype-specific effect of NUP210 loss. Live-cell imaging demon-
strated that nuclear size was significantly decreased in Nup210 KO
cells throughout the cell cycle (Fig. 4n), suggesting that the loss of
NUP210 might increase heterochromatinization32. Co-IP in Nup210
KO cells revealed a decreased association of H3.1/3.2 with Lamin B1
and increased association with heterochromatin-modifying enzymes,
SUV39H1 (catalyzing H3K9me3) (Fig. 4o) and EZH2 (Fig. 4p), a
key component of the polycomb-repressive complex 2 (PRC2)
(catalyzing H3K27me3)33. Further analysis of other PRC2 compo-
nents revealed an increased association of EZH2 with SUZ12
(Fig. 4q) and H3K27me3 (Fig. 4r) in Nup210 KO cells. Taken
together, these results suggest that NUP210 restricts the recruitment
of heterochromatin-modifying enzymes to H3.1/3.2 at the nuclear
periphery.
NUP210 loss increases heterochromatin spreading and
decreases expression of cell adhesion/migration-related genes.
To test whether NUP210 loss promotes heterochromatin for-
mation, we performed chromatin immunoprecipitation followed
by sequencing (ChIP-seq) analysis of NUP210, H3K27me3
(repressive), and H3K4me3 (active) histone marks. ChIP-seq
analysis revealed that the majority (55.33%) of the NUP210 peaks
are within intergenic regions (Supplementary Fig. 6a), with
19.01% of NUP210 peaks within 10 kb of transcription start sites
(TSS). The rest of the peaks were found within gene bodies, but
mainly enriched in 3′-transcription end sites of the genes (Sup-
plementary Fig. 6b). Moreover, 40% (9962 peaks) of NUP210
peaks overlap with H3K27me3 (false discovery rate (FDR) < 0.05)
(Supplementary Fig. 6c), indicating H3K27me3 enrichment sur-
rounding the NUP210-bound gene bodies. In addition, in Nup210
KO cells, increased H3K27me3 over NUP210-bound gene bodies
was observed (Fig. 5a), suggesting that these genes were under-
going heterochromatinization. There was an overall expansion of
H3K27me3 peak regions, suggesting H3K27me3-marked het-
erochromatin spread (Fig. 5b). Integration of ChIP-seq dataset for
active enhancer (H3K27Ac)34 revealed that NUP210 was enri-
ched at regions surrounding H3K27Ac (Supplementary Fig. 6d).
Loss of NUP210 resulted in an increase in the repressive
H3K27me3 mark across these enhancer regions, suggesting
NUP210 might be preventing heterochromatin from spreading
across distal regulator elements as well as gene bodies.
Since enhancer–promoter interactions are critical for the
regulation of gene expression35,36 and H3.1/3.2 is preferentially
enriched at the poised promoters, we applied structured illumina-
tion microscopy (SIM) to examine the intranuclear distribution of
H3K4me3 (promoter) and H3K27Ac (enhancer) marks in Nup210
KO cells. Although there were no significant changes in H3K4me3
volume in Nup210 KO cells, H3K27Ac volume was significantly
reduced (Supplementary Fig. 6e, f and Supplementary Movies 3 and
4), suggesting the decrease of enhancer regions. There was no
noticeable alteration of H3K4me3 distribution in relation to H3.1/
3.2 foci in Nup210 KO cells (Supplementary Fig. 6g). However,
ChIP-seq of H3K4me3 revealed that the TSS of 1199 genes showed
2-fold decreased enrichment of H3K4me3 in Nup210 KO cells
(Fig. 5c). RNA-seq of Nup210 KD 4T1 cells identified 282
downregulated (2-fold) and 249 upregulated (2-fold) genes
(Supplementary Fig. 6i), 62 of which had H3K4me3 loss at the
promoter and ≥2-fold decreased expression (Fig. 5d) and thus were
likely to be direct targets of NUP210 regulation. Gene ontology
(GO) analysis on the 62 genes showed enrichment of cell migration
and chemotaxis processes (Fig. 5e), including chemokines (Ccl2,
Cxcl1, and Cxcl3), cytokine (Il-1a), and cell adhesion (Postn,
Serpine1, Itga7, Itgb2) molecules (Fig. 5f and Supplementary Fig. 6j).
Similar transcriptional changes were also observed in NUP210-
depleted 6DT1 cell line (Supplementary Fig. 6k). Integration of
publicly available high-throughput chromosome conformation
capture (Hi-C) data from mouse embryonic stem cells (mESCs)37
using the 3D-Genome Browser38 revealed that H3K27me3
accumulated across the Cxcl and Ccl2 loci topologically associated
domains (TADs) in Nup210 KO cells (Fig. 5g), and was
accompanied by a marked loss of H3K4me3 at the promoters of
these genes, implying that NUP210 loss results in heterochroma-
tinization across the Cxcl/Ccl2 enhancer and promoter regions.
To test whether the expression of NUP210-regulated genes can
be rescued in Nup210 KO cells by inhibiting heterochromatiza-
tion, cells were treated with an EZH2 inhibitor GSK126, which
prevents H3K27me3 modification. Treatment with GSK126
significantly increased the expression of Ccl2, Cxcl1, Cxcl3, Postn,
and Il-1a (Fig. 5h), suggesting that they were suppressed through
heterochromatinization in Nup210 KO cells. In contrast, GSK126
treatment decreased the expression of Itga7, Itgb2, and Serpine1,
implying that they were either not directly suppressed by
heterochromatinization or could be suppressed by a nonspecific
effect of the drug. Interestingly, perinuclear distribution of H3.1/
3.2 and nuclear size was significantly restored in GSK126-treated
Nup210 KO cells (Fig. 5i, j). Live-cell tracking of nuclear size
further supported the observation that GSK126 treatment
significantly rescued the nuclear size of Nup210 KO cells (Fig. 5k).
These results are consistent with the role of NUP210 in preventing
H3K27me3 heterochromatinization of perinuclear DNA.
Fig. 2 NUP210 expression is associated with poor outcome in human ER+ breast cancer patients. a Association of NUP210 amplification on the overall
survival (OS). b Association of NUP210 mRNA level on the OS and c DMFS in ER+ patients. d NUP210 mRNA level within METABRIC dataset.
Kruskal–Wallis ANOVA with Dunn’s multiple comparison test. The box extends from 25th to 75th percentile, whiskers extend from smallest values to the
largest values, and the horizontal line represents median. ‘n’ in X-axis is the number of patients in each subtype. e NUP210 protein expression in the human
normal mammary gland. Scale bar= 100 μm. f Immunohistochemistry and nuclear envelope quantification g of NUP210 in the primary tumors of ER+ and
ER− cancer patients. Scale bar= 100 μm. Mann–Whitney U test, error bar represents median with interquartile range. h Immunohistochemistry analysis
and nuclear envelope quantification. i NUP210 protein in the lymph node metastases of ER+ and ER− patients. Scale bar= 100 μm. Mann–Whitney U test,
error bar represents median with interquartile range. j NUP210 mRNA level in multiple human breast cancer metastatic sites. Kruskal–Wallis ANOVA with
Dunn’s multiple comparison test. The box extends from 25th to 75th percentile, whiskers extend from smallest values to the largest values, and the
horizontal line represents median. ‘n’ in X-axis is the number of patients analyzed per condition.
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Fig. 3 Depletion of Nup210 in 4T1 metastatic cancer cells reduces lung metastasis in mice. a Western blot of Nup210 knockdown (KD) in 4T1 cells. b
Primary tumor weight, c representative lung images, and d lung metastases count and lung metastases count normalized to primary tumor weight in
orthotopically transplanted Nup210 KD 4T1 cells. ANOVA with Tukey’s multiple comparison test, mean ± s.d. sh-Ctrl, n= 10; sh # 1, n= 10; sh # 4, n= 9
mice. e Western blot showing CRISPR/Cas9-mediated knockout (KO) of Nup210 in 4T1 cells. f Primary tumor weight, g representative lung images, h lung
metastases count and tumor-normalized metastases count after orthotopic transplantation of Nup210 KO 4T1 cells. ANOVA with Tukey’s multiple
comparison test, mean ± s.d. n= 10 mice per group. i DNA content analysis with EdU incorporation of the different stages of the cell cycle in sg-Ctrl and
Nup210 KO 4T1 cells. j Quantification of cell cycle stage distribution in sg-Ctrl and Nup210 KO 4T1 cells.Two-tailed t test, mean ± s.e.m, n= 3 biological
replicates. k Western blot (left) and qRT-PCR (right) of NUP210 overexpression in 4T1 cells. Two-tailed t test, mean ± s.e.m, n= 3 biological replicates. l
Primary tumor weight, m representative lung images, and n lung metastases count after orthotopic transplantation of NUP210-overexpressing 4T1 cells.
Mann–Whitney U test, mean ± s.d. n= 10 mice per group.
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Nup210 loss is associated with differential repositioning of cell
migration-related gene loci. To determine whether NUP210
regulates its target genes through anchoring TADs to the nuclear
periphery, 3D-DNA fluorescent in situ hybridization (FISH) was
performed. FISH probes were generated from bacterial artificial
chromosome clones (~2Mb) spanning Cxcl, Postn, Ccl2, and
Itgb2 genomic regions. As expected, the majority of the FISH
spots were observed near the nuclear periphery in aneuploid
4T1 cells (Supplementary Fig. 7a). Interestingly, in Nup210 KO
cells, Cxcl, Postn, and Itgb2 loci were repositioned within the
nucleus (Supplementary Fig. 7b), with Cxcl and Itgb2 loci repo-
sitioned closer to the nuclear periphery, and the Postn locus
repositioned away from the periphery. Radial positioning of the
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distance of Ccl2 FISH spots to heterochromatin foci was sig-
nificantly reduced in Nup210 KO (Supplementary Fig. 7c) cells.
These results suggest that NUP210 loss is associated with altered
chromatin topology and nuclear positioning of cell migration-
related gene loci. Since three-dimensional chromatin domains are
organized into transcriptionally active (A compartment) and
repressive (B compartment) compartments within the nucleus39,
repositioning of these genes in Nup210 KO cells is consistent with
their repositioning into repressive B compartment due to the
heterochromatinization.
NUP210 is mechanosensitive and regulates focal adhesion, cell
migration, and invasion. Alterations in cell adhesion/migration-
related gene expression can lead to changes in cellular adhesion, a
critical phenotype in metastatic progression. Nup210 KO cells
exhibited less spread, round morphology when they were grown on
type I collagen and fibronectin matrices (Fig. 6a). Staining for
phospho-FAK (Y397) and phalloidin revealed that loss of Nup210
significantly decreased the focal adhesions (area and count), actin
stress fibers, and cell spreading when plated on type I collagen or
fibronectin (Fig. 6b, c). Similar results were obtained in the case of
Nup210-knockdown 4T1 (Supplementary Fig. 8a), 6DT1 (Supple-
mentary Fig. 8b, c), and human MDA-MB-231 cells (Supplemen-
tary Fig. 8d). Consistently, the protein level of phospho-FAK (Y397)
was also decreased in NUP210-depleted mouse (Supplementary
Fig. 8e–g) and human (Supplementary Fig. 8h, i) breast cancer cells.
In addition, there was a significant decrease of phospho-FAK
(Y397) staining within the Nup210 KO primary tumors, suggesting
that NUP210 loss also affects focal adhesion in vivo (Fig. 6d). To
test whether the constitutively active FAK can rescue the metastasis
defects of Nup210 KO cells, we stably expressed Myc-tagged FAK in
Nup210 KO cells (Fig. 6e). Although there was no significant effect
on primary tumors in FAK-expressing cells (Fig. 6f), both tumor-
normalized lung metastases count (Fig. 6h) and metastasis inci-
dence (Fig. 6i) were significantly rescued indicating that NUP210 is
mediating its effects on metastasis through the focal adhesion sig-
naling pathway.
As focal adhesion contributes to the mechanical response of
tumor cells, we asked whether NUP210 is mechanosensitive in
metastatic cells. 4T1 cells grown on soft/low stiffness (0.2 kPa)
condition exhibited a round colony-like morphology, while on
the higher stiffness conditions (12 kPa), these cells exhibited a
more spread morphology (Fig. 7a). Increased protein levels of
p-FAK (Y397) and NUP210 were found in the higher stiffness
condition (Fig. 7b), indicating that NUP210 protein is mechan-
osensitive in 4T1 cells. Moreover, NUP210 protein level was
higher on cells grown on type I collagen than fibronectin
(Supplementary Fig. 8j), suggesting that NUP210 might be
sensitive to different ECM compositions. Many of the NUP210-
regulated genes were also sensitive to higher ECM stiffness
conditions (Fig. 7c). However, unlike protein level, transcript
levels of Nup210, FAK (Ptk2), as well as a known mechan-
osensitive transcription factor, Yap1, were not significantly
upregulated in higher stiffness conditions. This result is consistent
with the previous observation that soft matrices tend to degrade
mechanosensitive proteins40 and rapid reduction of NUP210
protein on soft matrix could be due to the post-transcriptional
loss of protein stability. NUP210-depleted cells exhibited
decreased spreading on the higher stiffness condition (Fig. 7d),
consistent with NUP210 contributing to mechanosensation. As
mechanosensation can occur through alteration of actin
dynamics41,42, treatment with an actin polymerization inhibitor,
cytochalasin D (CytoD), in 4T1 cells demonstrated that NUP210-
depleted cells had decreased recovery of actin polymerization, as
marked by phalloidin staining of actin stress fibers (Supplemen-
tary Fig. 8k). As the mechanical response is mediated through
alteration of actomyosin tension, staining with phospho-myosin
light chain 2 (MLC2-S19) and phalloidin revealed a decreased
association of F-actin and activated myosin II (phospho-MLC2-
S19) in Nup210 KO cells grown on type I collagen and fibronectin
matrices (Supplementary Fig. 8l). To further investigate the
actomyosin contractility of Nup210-depleted cells, we stably
expressed a fluorescently tagged stochiometric F-actin (F-tractin)
and myosin II activity reporter (MLC2)43 in 6DT1 cells and
performed live-cell imaging analysis. On type I collagen, both
F-tractin and MLC2 remained associated at the actin stress fibers
and lamellipodia in control cells compared to Nup210 knock-
down cells where they were localized at the nuclear periphery
(Fig. 7e). In CytoD-treated conditions, F-tractin and MLC2
association was disrupted. After CytoD washout, control cells
quickly recovered and maintained their F-tractin–MLC2 associa-
tion at the lamellipodia (Supplementary Movie 5). In contrast,
this association was disrupted in Nup210 knockdown cells and
MLC2 mainly localized at the nuclear periphery (Supplementary
Movie 6). These results suggest that the loss of NUP210 is
associated with decreased actomyosin contractility of cancer cells.
As actomyosin contractility is critical for cell migration and
invasion, live-cell imaging analysis of cell migration was
performed and revealed a significant decrease of cell migration
in Nup210 KO cells than sg-Ctrl cells (Fig. 7f and Supplementary
Movies 7–9). A significant reduction of cell invasion was also
observed in NUP210-depleted 4T1 (Fig. 7g) and 6DT1 cells
(Fig. 7h). Taken together, these results demonstrate that NUP210
is part of a sensor of the extracellular matrix (ECM) stiffness and
composition that significantly affects the migratory and invasive
ability of tumor cells.
Fig. 4 H3.1/3.2 interacts with NUP210 and is redistributed to heterochromatin foci upon NUP210 loss. a NUP210 coimmunoprecipitation (Co-IP)-LC-
MS analysis. b Peptide count in LC-MS analysis with endogenous and Myc-tag-NUP210 antibodies. c Association of histone H3.1 amplification on the
overall survival of breast cancer patients. d Co-IP of NUP210-Myc with H3.1/3.2 in 4T1 cells. e Co-IP of endogenous H3.1/3.2, NUP210, and Lamin B1 in
4T1 cells. f Reciprocal Co-IP of Flag-H3.1 and NUP210-Myc in HEK293FT cells. g Representative immunofluorescence images of H3.1/3.2 and NUP210-Myc
localization in 4T1 cells. Scale bar= 5 μm. h Representative images of H3.1/3.2 and H3K27me3 in sg-Ctrl and Nup210 KO 4T1 cells. Scale bar= 5 μm. i
H3.1/3.2 and H3K27me3 nuclear periphery vs total nuclear intensity ratio in Nup210 KO 4T1 cells. Mann–Whitney U test, error bar represents median with
interquartile range. ‘n’ equals the number of cells analyzed. j Representative images of H3.1/3.2 localization with H3K9me3 in Nup210 KO 4T1 cells. Scale
bar= 5 μm. k (Left) H3.1/3.2 (heterochromatin foci vs total nucleus) and (Right) H3K9me3 (periphery vs total nuclear intensity) intensity ratios in Nup210
KO 4T1 cells. Mann–Whitney U test, error bar represents median with interquartile range. ‘n’ equals the number of cells analyzed. l 3D reconstruction of
H3.1/3.2 and H3K9me3 distribution in Nup210 KO 4T1 cells. The intensity was adjusted to visualize distinct foci. Scale bar= 2 μm.m Representative images
of H3.1/3.2 distribution at the nucleolar (nucleolin) periphery in Nup210 KO 4T1 cells. Scale bar= 5 μm. n Live-cell imaging of nuclear size of Nup210 KO
4T1 cells before and after mitosis. Thin line, single nuclear size traces; thick line, median of nuclear size, box plot represents average nuclear size. ‘n’ equals
the number of cells analyzed per condition. Kruskal–Wallis ANOVA with Dunn’s multiple comparison test. The box represents 25th to 75th percentile, the
whiskers represent the data range, and the horizontal line represents the median. o Co-IP of H3.1/3.2 with Lamin B1, SUV39H1, and H3K9me3 in Nup210
KO 4T1 cells. p Co-IP of H3.1/3.2 with EZH2; q EZH2 and SUZ12; r EZH2 and H3K27me3 in Nup210 KO 4T1 cells.
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NUP210 is a LINC (linker of nucleoskeleton and cytoskeleton)
complex-associated protein and regulates mechanosensitive
gene expression. As mechanotransduction is mediated through
the nuclear envelope-anchored LINC complex proteins42,44, we
asked whether NUP210-dependent mechanical response is
mediating through its association with LINC complex proteins.
Co-IP revealed that NUP210 preferentially interacts with LINC
complex protein SUN2, but not SUN1 (Fig. 8a). Immuno-
fluorescence imaging showed that NUP210 was associated with
SUN2 at the nuclear periphery (Fig. 8b). Interestingly, the peri-
nuclear localization of SUN1 and SUN2 was significantly dis-
rupted in Nup210 KO cells (Fig. 8c). SUN2 was distributed
diffusely throughout the cells with a significant increase in
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Fig. 5 Loss of NUP210 is associated with H3K27me3-marked heterochromatin spreading in 4T1 cells. a H3K27me3 peak enrichment on gene bodies in
Nup210 KO cells within NUP210-enriched regions. b H3K27me3 ChIP-seq profile in sg-Ctrl and Nup210 KO cells. c H3K4me3 ChIP-seq profile on gene
promoters in sg-Ctrl and Nup210 KO cells. d Overlap of genes with H3K4me3 loss on the promoter and downregulated expression in Nup210 KD cells. e
Gene Ontology (GO) analysis of overlapped genes from (d). f qRT-PCR analysis of cell migration-related genes in Nup210 KO and KD 4T1 cells. Multiple
two-tailed t test, mean ± s.e.m, n= 3 biological replicates (sg-ctrl vs Nup210 KO), n= 4 biological replicates (sh-Ctrl vs sh-Nup210). g Representative
ChIP-seq (NUP210-, H3K27Ac-, H3K27me3- and H3K4me3) tracks with predicted TADs within Cxcl and Ccl2 region. h qRT-PCR analysis of cell migration-
related genes in DMSO- and GSK126-treated Nup210 KO 4T1 cells. Multiple two-tailed t test, mean ± s.e.m, n= 3 biological replicates. i Representative
images of H3.1/3.2 and H3K27me3 distribution in DMSO- and GSK126-treated Nup210 KO cells. Scale bar= 5 μm. j H3.1/3.2 intensity ratio, H3K27me3
intensity and nuclear area quantification in DMSO- and GSK126-treated Nup210 KO 4T1 cells. Kruskal–Wallis ANOVA with Dunn’s multiple comparison
test, error bar represents median with interquartile range. ‘n’ in X-axis is the number of cells analyzed per condition. k Live-cell tracking of a nuclear area in
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Fig. 6 Nup210 regulates focal adhesion of tumor cells. a Representative brightfield images of 4T1 Nup210 KO cells on type I collagen and fibronectin. Scale
bar= 100 μm. b Representative images of p-FAK (Y397) focal adhesions and F-actin in sg-Ctrl and Nup210 KO cells on type I collagen and fibronectin.
Scale bar= 10 μm. c Quantification of focal adhesion area, count, and cell spreading in sg-Ctrl and Nup210 KO 4T1 cells. ANOVA with Tukey’s multiple
comparison correction. The box represents the 25th to 75th percentile, whiskers represent data range, and the horizontal line represents the median. d
(Left) Immunostaining of Nup210 KO (KO-N13) 4T1 primary tumors with p-FAK Y397 and pan-cytokeratin (Pan-CK) antibodies. Scale bar= 50 μm. (Right)
quantification of p-FAK Y397 signal in the Pan-CK-stained tumor area. N= 5 mice per condition, ~10 independent fields per mouse tumor section.
Mann–Whitney U test, median with interquartile range. e Western blot of myc-tagged FAK overexpression in Nup210 KO 4T1 cells. f Primary tumor weight
in FAK-overexpressing Nup210 KO (KO-N13) 4T1 cells. ANOVA with Tukey’s multiple comparison correction, mean ± s.d. n= 10 mice per group. g
Representative lung images of the mice injected with FAK-overexpressing Nup210 KO cells. h Lung metastasis count and metastases normalized to tumor
weight in FAK-overexpressing Nup210 KO cells. ANOVA with Tukey’s multiple comparison correction, mean ± s.d. n= 10 mice per group. i Metastasis
incidence in mice injected with FAK-overexpressing Nup210 KO cells. χ2 test with Bonferroni correction. n= 10 mice per group.
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addition, the ratio of the nuclear periphery to total nuclear
intensity was significantly decreased in the case of both SUN2 and
SUN1. Since NUP210 was affecting the LINC complex, we looked
at the nuclear lamina of Nup210 KO cells more closely. Although
there were no significant changes in total Lamin B1 intensity,
total Lamin A/C intensity was significantly increased in Nup210
KO cells (Fig. 8e, f). In contrast, the ratio of the nuclear periphery
tothe total intensity of both Lamin B1 and Lamin A/C was sig-
nificantly reduced in Nup210 KO cells. More interestingly, 3D
surface reconstruction revealed that both Lamin B1 and Lamin A/
C appeared as crevices inside the nucleus of Nup210 KO cells
(Fig. 8g and Supplementary Movies 10 and 11). Since increased
Lamin A/C level has previously been shown to increase
nuclear stiffness resulting in decreased cell migration and
tumorigenesis45,46, we measured the level of total Lamin A/C
protein using western blot. However, the total Lamin A/C protein
level was not significantly changed in Nup210 KO cells (Supple-
mentary Fig. 9a), suggesting that the increased Lamin A/C
intensity in immunofluorescence was probably due to the
heterochromatin-mediated decrease of nuclear size, which resul-
ted in a higher concentration of Lamin A/C at the nuclear
envelope. Subcellular fractionation revealed that SUN2 and
Lamin B1 proteins are mislocalized in the cytoplasmic fraction of
Nup210 KO cells (Fig. 8h). There was an overall decrease of SUN1
protein in the nuclear fraction of Nup210 KO cells. The nuclear
translocation of known mechanosensitive proteins (MRTF-A and
YAP) was not affected in Nup210 KO cells (Fig. 8h). Rather, there
was an overall decrease of MRTF-A/MKL1 in nuclear fraction
and the level of YAP was decreased in both cytoplasmic and
nuclear fraction of Nup210 KO cells. This result suggests that the
role of NUP210 in mechanosensation is independent of the
canonical nuclear translocation mechanism of mechanosensitive
proteins41,47. However, the overall distribution of nuclear pore
was not affected by Nup210 KO (Supplementary Fig. 9b). In
addition, the dynamic organization of nuclear pore was not
compromised in NUP210-depleted cells as confirmed by fluor-
escence recovery after photobleaching (FRAP) analysis of GFP-
tagged nuclear pore protein POM121 (Supplementary Fig. 9c).
These results suggested that the loss of NUP210 is associated with
alteration of nuclear lamina and uncoupling of LINC complex
machinery resulting in altered mechanical response, cell migra-
tion, and metastasis.
We then investigated the link between the alteration of
mechanotransduction machinery and transcriptional suppres-
sion of Nup210 KO cells. We have previously shown that
metastasis susceptibility genes RRP1B and the short isoform of
BRD4 (BRD4-SF) interact with LINC complex proteins at the
nuclear lamina19,48. Similarly, BRD4 has been linked to
mechanotransduction49 and metastasis50. So, we hypothesized
that NUP210 is probably associated with this protein complex
and mediates the interaction with H3.1/3.2-associated chromatin
to regulate the gene expression in metastasis. Co-IP revealed that
endogenous histone H3.1/3.2 was associated with NUP210,
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Fig. 7 NUP210 is mechanosensitive and regulates tumor cell migration and invasion. a Representative images of 4T1 cells on fibronectin-coated hydrogel
layers of soft (0.2 kPa) and stiff (12 kPa) matrices. Scale bar= 10 μm. b (Left) Western blot of NUP210, p-FAK Y397, and T-FAK (Total FAK) proteins of
4T1 cells grown on soft or stiff matrices. (Right) Quantification of signals normalized to T-FAK intensity. c qRT-PCR of Nup210-regulated and known
mechanosensitive genes (Ier3, Mrtf-a, and Yap1) genes in soft and stiff matrices. Multiple two-tailed t test, mean ± s.e.m. n= 3 biological replicates. d
Morphology of sh-Ctrl and Nup210 KD 4T1 cells in soft and stiff matrices. Scale bar= 10 μm. e Live-cell imaging of F-tractin-MLC2 reporter transduced
6DT1 sh-Nup210 cells. Cells were treated with cytochalasin D for 1 h and imaged overnight after drug washout. Scale bar= 10 μm. f (Left) cell migration
tracks (red) of sg-Ctrl and Nup210 KO 4T1 cells. (Right) Quantification of cell speed. Kruskal–Wallis ANOVA with Dunn’s multiple comparison correction,
sg-Ctrl (n= 847 cells), KO-N9 (n= 124 cells), KO-N13 (n= 375 cells), error bar represents median with interquartile range. g Quantification (left) and
representative images (right) of cell invasion for 4T1 (at 48 h) and (h) 6DT1 (at 24 h) NUP210-depleted cells. Two-tailed t test, mean ± s.d. n= 3 biological
replicates. Scale bar= 100 μm.
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(Fig. 8i). BRD4-SF also interacts with NUP210 in these cells
(Fig. 8j). H3.1/3.2–SUN2 interaction was also evident in human
breast cancer cells MCF7 and MDA-MB-231 (Fig. 8k). We then
tested the necessity of either NUP210 or BRD4-SF in bridging
the interaction between the LINC complex machinery and H3.1/
3.2 on chromatin. Although the interaction of SUN2 with H3.1/
3.2 was unperturbed in Nup210 KO cells (Supplementary
Fig. 10a), complete disruption of H3.1/3.2–NUP210 interaction
and partial disruption of H3.1/3.2–SUN2 interactions were
observed in bromodomain inhibitor JQ1-treated 4T1 cells
(Fig. 8l). This result suggested that BRD4-SF is crucial for
bridging the interactions among the molecules in this putative
complex. Interestingly, similar to Nup210 KO, redistribution of
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heterochromatin mark H3K27me3 was observed in bromodo-
main inhibitor JQ1-treated cells (Fig. 8m, n). Live-cell imaging of
nuclear size also revealed that JQ1 treatment significantly
decreased nuclear size (Fig. 8o). Decreased expression of
Nup210 and some of the Nup210-dependent genes was found
in JQ1-treated cells (Fig. 8p). Similar gene expression changes
were also observed in BRD4-SF-specific knockdown 4T1 cells
(Fig. 8q). Taken together, NUP210 is a LINC complex-associated
protein and suggests that NUP210 is a regulator of mechan-
osensitive gene expression program through interacting with
BRD4-SF-H3.1/3.2-associated chromatin.
To determine the cause and effect relationship of NUP210-
dependent response, we treated 4T1 cells with actin polymeriza-
tion inhibitor CytoD and a global heterochromatin promoting
H3K27me3-specific histone demethylase inhibitor (GSKJ4).
Actomyosin organization was drastically reduced in CytoD-
treated cells as shown by F-actin and p-MLC2-S19 immunostain-
ing (Supplementary Fig. 10b). Unlike CytoD, GSKJ4 had a minor
effect on F-actin stress fibers, but it disrupted p-MLC2-S19
distribution, suggesting the alteration of actomyosin tension in
GSKJ4-treated cells. Treatment with both of these drugs resulted
in the redistribution of histone H3.1/3.2 from the nuclear
periphery to heterochromatin foci, similar to the effect seen in
Nup210 KO cells (Supplementary Fig. 10c, d). Furthermore,
CytoD treatment showed additional effects such as micronuclei
and double nuclei formation. Treatment of cells with GSKJ4
resulted in a similar transcriptional profile as Nup210-depleted
cells, which was not recapitulated by the treatment with CytoD
(Supplementary Fig. 10e). Nup210 mRNA level was slightly
decreased in CytoD-treated cells, but unchanged at the protein
level (Supplementary Fig. 10f). Despite the unchanged level of
Nup210 mRNA in GSKJ4-treated cells, a significant decrease of
NUP210 protein level was observed, suggesting post-
transcriptional downregulation of Nup210 (Supplementary
Fig. 10f). Moreover, decreased levels of focal adhesion (p-FAK,
T-FAK) and LINC complex protein (SUN2) were found in the
GSKJ4-treated condition. Decreased Lamin B1 protein levels by
both drugs indicated that they are also capable of disrupting the
nuclear lamina. Taken together, these results suggest a positive
feedback loop between NUP210-dependent heterochromatin
regulation and actin cytoskeletal tension, and the change in focal
adhesion is likely to be the consequence of disrupting this
feedback loop (Supplementary Fig. 10g).
NUP210 regulates circulating tumor cells (CTCs) in mice.
Many of the NUP210-regulated genes are secretory molecules like
cytokines (IL-1α), chemokines (CCL2, CXCL1, CXCL3), and
adhesion molecules (POSTN, SERPINE1), some of which have
known prometastatic roles in breast cancer51–54. Cytokine array
analysis revealed decreased secretion of cytokines (IL-1α), che-
mokines (CCL2, CXCL1), and adhesion molecules (POSTN,
SERPINE1) in Nup210 knockdown 4T1 cells (Fig. 9a). To
investigate whether NUP210 mediates its effect on focal adhesion
and cell migration through transcriptional control of secretory
molecules, Ccl2 was chosen as a candidate and examined for
NUP210 KO-associated phenotypes. Knockdown of Ccl2 in
4T1 cells (Fig. 9b) resulted in decreased p-FAK (Y397) (Fig. 9c),
decreased focal adhesion, and cell spreading (Fig. 9d, e). More-
over, a significant decrease in cell migration was observed upon
Ccl2 knockdown phenocopying the loss of NUP210 in these cells
(Fig. 9f).
We then tested whether recombinant CCL2 can rescue the
spreading defect of Nup210 KO cells. Treating with recombinant
CCL2 for 5 h moderately rescued the spreading phenotype of
Nup210 KO cells (Fig. 9g). To test whether CCL2 can rescue the
metastatic defect of Nup210 KO cells, we overexpressed Ccl2 in
Nup210 KO cells through lentiviral delivery. However, only ~25%
of Ccl2 expression was rescued (Fig. 9h). Injecting these Ccl2-
overexpressing cells into mice did not have a significant effect on
primary tumors (Fig. 9i). Although Ccl2 expression in Nup210
KO cells showed an increased trend of lung metastasis, it was not
statistically significant (Fig. 9j, k). This result suggests that either
the level of the rescue of Ccl2 expression in Nup210 KO cell was
not sufficient to have a significant effect on metastasis or rescuing
with a single gene from the NUP210 transcriptional network
cannot fully recover the NUP210 loss.
As Nup210-depleted cancer cells exhibited adhesion defects
and decreased the level of secretory molecules necessary for
tumor cell adhesion to endothelial wall55, we speculated that
NUP210 loss might affect the CTC levels. Therefore, based on
CD45−/CK+ staining, putative CTCs were isolated 28 days after
orthotopic implantation of 6DT1 cells56. Under these conditions,
approximately ~0.5–1% of the cells in the blood of 6DT1-sh-Ctrl
tumor-bearing mice were CD45−/CK+ putative CTCs. In
contrast, CTC counts in mice with Nup210-depleted tumors
were indistinguishable from the FVB tumor-free control (Fig. 9l).
These results suggest that the effect on focal adhesion and cell
migration in NUP210-depleted cells is mediated through the
NUP210-dependent transcriptional control of cytokine/chemo-
kine secretory pathways that are required for tumor cell
extravasation or for the survival of cells within the bloodstream.
In summary, our model suggests that growth factors and
integrins transmit the mechanical signals via NUP210–SUN1–-
SUN2–BRD4–SF–H3.1/3.2 protein complex to regulate mechan-
osensitive genes (Fig. 9m), which in turn activate downstream
signaling pathways necessary for focal adhesion, cell migration, and
metastasis. In Nup210 KO cells, this signaling cascade is disrupted,
thereby decreasing metastasis.
Fig. 8 NUP210 is a LINC complex-associated protein mediating chromatin connection through the short isoform of BRD4. a Coimmunoprecipitation of
myc-tagged NUP210 with SUN1 and SUN2. b Colocalization of SUN2 and myc-tagged NUP210. Scale bar= 5 μm. c Distribution of SUN1 and SUN2 in
Nup210 KO (KO-N13) 4T1 cells. Scale bar= 10 μm. d Quantification of SUN2 and SUN1 intensity in Nup210 KO 4T1 cells. Mann–Whitney U test, error bar
represents median with an interquartile range. ‘n’ equals the number of cells analyzed. e Distribution of Lamin B1 and Lamin A/C in Nup210 KO 4T1 cells.
MIP maximum intensity projection. Scale bar= 5 μm. f Quantification of Lamin B1 and Lamin A/C intensity in Nup210 KO 4T1 cells. Mann–Whitney U test,
error bar represents median with an interquartile range. ‘n’ equals the number of cells analyzed. g 3D reconstruction of Lamin B1, Lamin A/C, and DAPI
(heterochromatin foci) distribution in Nup210 KO 4T1 cells. Scale bar= 2 μm. h Subcellular fractionation of LINC complex proteins and mechanosensitive
MRTF-A and YAP in Nup210 KO 4T1 cells. i Co-IP of H3.1/3.2 with LINC complex proteins SUN2, BRD4 short isoform (BRD4-SF), and RRP1B in 4T1 cells. j
Co-IP of V5-tagged BRD4-SF with NUP210 in 4T1 cells. k Co-IP of H3.1/3.2 and SUN2 in human MCF7 and MDA-MB-231 cell line. l Co-IP of H3.1/3.2 with
NUP210 and SUN2 in JQ1-treated 4T1 cells. m Distribution of H3.1/3.2 and H3K27me3 in 4T1 cells treated with bromodomain inhibitor JQ1. Scale
bar= 5 μm. n Quantification of H3.1/3.2 and H3K27me3 intensity in JQ1-treated 4T1 cells. Mann–Whitney U test, error bar represents median with an
interquartile range. ‘n’ equals the number of cells analyzed. o Live-cell tracking of nuclear size in DMSO control (n= 122) and JQ1-treated 4T1 cells
(n= 127). p qRT-PCR of NUP210-regulated genes in JQ1-treated 4T1 cells. Two-tailed t test, mean ± s.e.m. n= 3 biological replicates. q qRT-PCR of
NUP210-regulated genes in BRD4-SF knockdown 4T1 cells. Two-tailed t test, mean ± s.e.m. n= 3.
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Discussion
Apart from providing structural support and nucleocytoplasmic
transport57, the role of the NPC in developmental gene
regulation has drawn much attention recently58–61. Although
NUP210 has been implicated in muscle differentiation28,62, cel-
lular reprogramming63, and T cell signaling64,65, its function in
human cancer was unknown. Here, we have identified Nup210 as
a potential metastasis susceptibility gene for human ER+ breast
cancer patients and demonstrated a previously unrecognized role
of nuclear pore proteins in sensing the mechanical stress of
the ECM.
The present study has important implications in the field of
cellular mechanosensing. The nucleus is regarded as a sensor of
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complex proteins are thought to serve as mechanotransducer to
regulate gene expression44. Despite being embedded in the
nuclear envelope, direct involvement of nuclear pore proteins in
mechanosensation remains unclear. Previous studies have focused
mainly on the translocation of mechanosensitive transcription
factors to the nucleus in a nucleocytoplasmic transport-
dependent manner40,41,47. In contrast, our study has identified
a transport-independent role of nuclear pore components in
regulating mechanosensitive, prometastatic genes through inter-
action with LINC complex proteins and chromatin. However, we
could not specifically rule out the causal effect of NUP210 loss
due to the potential positive feedback loop between hetero-
chromatin regulation and actin cytoskeletal tension. Further
studies will be necessary to fully understand the mechanism of
NUP210 in regulating cellular mechanosensation.
Intriguingly, many of the NUP210-regulated genes were
immune molecules like chemokines and cytokines. This result has
important implications since rapid transcriptional activation and
secretion of immune molecules are required to induce an immune
response66. Consistent with T cell defects in NUP210-deficient
mice64, the NPC might be essential for inducing an immune
response. During metastasis, cancer cells may exploit this
mechanism for robust transcription of these genes, which then
promote their migration into distant organs in an autocrine
fashion.
Mechanistically, we have demonstrated that the loss of
NUP210 is associated with decreased peripheral localization of
H3.1/3.2 and increased enrichment near heterochromatin foci. In
support of this observation, we found increased accumulation of
H3K27me3-marked heterochromatin in Nup210 KO cells. These
results suggest a role for NUP210 as a chromatin barrier
insulator-binding protein. The NPC has been described as a
heterochromatin barrier component of the nuclear lamina67,68.
Loss of barrier insulator elements is associated with an increased
spreading of heterochromatin marks to adjacent actively tran-
scribing gene loci69. Since Nup210 loss was associated with
H3K27me3-marked heterochromatin spreading, NUP210 is
probably acting as a barrier of H3K27me3-mediated hetero-
chromatin spread to adjacent loci at the nuclear pore.
The potential enrichment of NUP210 at active enhancers and
its association with chromatin reader BRD4-SF is consistent with
the previous observation that the oncogenic properties of BRD4-
SF are partly mediated through enhancer regulation50. Nuclear
pores can be a scaffold of enhancer–promoter contact mediating
transcriptional activation of poised genes61. It is therefore con-
ceivable that in response to higher stiffness of the extracellular
microenvironment, NUP210 can facilitate the interaction of
LINC complex with BRD4-SF and histone H3.1/3.2-marked
enhancer regions to establish distal regulatory element interaction
with poised promoters of mechanosensitive genes necessary for
metastatic progression.
Treating Nup210 KO cells with an EZH2 inhibitor (GSK126)
could partially rescue the peripheral distribution of H3.1/3.2 and
mechanosensitive gene expression. This has important clinical
implications since EZH2 is a therapeutic target for multiple
malignancies and some EZH2 inhibitors are currently in clinical
trials70,71. In breast cancer, both tumor-promoting and inhibitory
effects have been described for EZH2 in a context-specific
manner72. Treating with an EZH2 inhibitor could adversely affect
the patient outcome through activation of the mechanosensitive
genes. In line with our observation, GSK126 treatment has been
shown to exhibit adverse effects via inhibiting antitumor
immunity73 and promoting inflammation74 in several preclinical
models of cancer.
In conclusion, we have identified a previously unrecognized
role for nuclear pore protein, NUP210, in mechanical sensing of
aggressive metastatic cancer cells. Future studies should deter-
mine whether blocking NUP210–chromatin interactions can be a
therapeutic strategy to prevent metastasis.
Methods
Mouse strains. Usage of animals described in this study was performed under the
animal study protocol LCBG-004 approved by the National Cancer Institute (NCI)
at Bethesda Animal Use and Care Committee. Animal euthanasia was performed
by anesthesia using Avertin injection, followed by cervical dislocation. Female
BALB/c (000651) and FVB/NJ (001800) mice were purchased from The Jackson
Laboratory.
Cell lines. Mouse mammary tumor cell lines, 4T07, 4T1, 6DT1, and MVT1, were
provided by Dr. Lalage Wakefield (NCI, NIH)26. These cell lines were grown in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) supplemented with 9%
fetal bovine serum (FBS) (Gemini), 1% L-glutamine (Gibco), and 1%
penicillin–streptomycin (Gemini). Human breast cancer cell lines, MDA-MB-231
and MCF7, were provided by Dr. Jeffrey E. Green (NCI, NIH) and grown in
DMEM with 9% FBS, 1% L-glutamine, and 1% penicillin–streptomycin. Human
293FT cells were purchased from Thermo Fisher Scientific and grown on the
medium mentioned above.
BACh sequencing analysis. Cells were expanded in DMEM at 37 °C to obtain
8–10 × 107 cells/condition/each experiment. BACh analysis was performed as
previously described with minor modifications75. Briefly, cells were collected by
centrifugation, washed twice in ice-cold cellular wash buffer (20 mM Tris-HCl pH
7.5, 137 mM NaCl, 1 mM EDTA, 10 mM sodium butyrate, 10 mM sodium
orthovanadate, 2 mM sodium fluoride, protease inhibitor cocktail (Roche) and
resuspended in (40 million cells/ml) hypertonic lysis buffer (20 mM Tris-HCl pH
7.5, 2 mM EDTA, 1 mM EGTA, 0.5% glycerol, 20 mM sodium butyrate, 2 mM
sodium orthovanadate, 4 mM sodium fluoride, and protease inhibitor cocktail).
Cells were distributed in 500 µl aliquots in 1.5 ml tubes and followed by the
addition of 500 µl of nuclease digestion buffer (40 mM Tris-HCl pH 8.0, 6 mM
MgCl2, 0.3% NP-40, and 1% glycerol) containing a 3-fold dilution (from 0.125 to
6 U/ml) of benzonase nuclease (Millipore). This was mixed gently and incubated
Fig. 9 NUP210 regulates circulating tumor cells in mice. a Cytokine analysis and quantification of boxed cytokines of supernatants from sh-Ctrl and
Nup210 KD 4T1 cells. b qRT-PCR analysis of Ccl2 KD in 4T1 cells. c Western blot of p-FAK Y397 and T-FAK proteins in Ccl2 KD 4T1 cells. d p-FAK (Y397)
focal adhesion and F-actin distribution in sh-Ctrl and Ccl2 KD 4T1 cells. Scale bar= 10 μm. e Quantification of focal adhesion area, count, and cell spreading
in sh-Ctrl and Ccl2 KD 4T1 cells. ANOVA with Tukey’s multiple comparison correction, box represents 25th to 75th percentile, whiskers represent data
range, and the horizontal line represents median. ‘n’ equals the number of cells analyzed. f Cell migration tracks and quantification of sh-Ctrl and Ccl2 KD
4T1 cells. Average cell speed analyzed by ANOVA with Dunnet’s multiple comparison test, mean ± s.e.m. ‘n’ equals the number of independent replicates. g
Brightfield images and quantification of cell area of 4T1 Nup210 KO cells treated with Ccl2. ANOVA with Tukey’s multiple comparison correction, box
represents 25th to 75th percentile, whiskers represent data range, and the horizontal line represents median. ‘n’ equals the number of cells analyzed. h
Western blot and signal quantification of Ccl2 overexpression in Nup210 KO 4T1 cells. i Tumor weight of mice injected with Ccl2-overexpressing Nup210 KO
4T1 cells. ANOVA with Tukey’s multiple comparison correction, mean ± s.d. For sg-Ctrl+Ctrl-OE and Nup KO+ Ctrl-OE, n= 10 mice; for Nup KO+ Ccl2-
OE, n= 9 mice. (j) Representative lung images from the mice from (i). k Lung metastases count and metastasis normalized to tumor weight from the mice
injected in panels i and j. ANOVA with Tukey’s multiple comparison test, mean ± s.d. For sg-Ctrl+Ctrl-OE and Nup KO+ Ctrl-OE, n= 10 mice; for Nup
KO+ Ccl2-OE, n= 9 mice. l (Top) Flow cytometry analysis of CD45−/CK+ circulating tumor cells (CTCs) and (bottom) quantification of CTCs in Nup210
KD 6DT1 cell-injected animals. Kruskal–Wallis ANOVA with Dunn’s multiple comparison test, mean ± s.d. Tumor-free, n= 3 mice; sh-Ctrl and sh-Nup # 4,
n= 10 mice. m Proposed model of NUP210’s metastatic role.
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for 3 min at 37 °C. Reactions were terminated by the addition of EDTA (10 mM
final concentration) and SDS (0.75% final concentration). Proteinase K was added
to a final concentration of 0.5 mg/ml and incubated overnight at 45 °C. DNA
fragments of 100–500 bp from a chromatin digestion were purified over sucrose
gradients76 and precipitated in 0.1 volume sodium acetate and 0.7 volume
isopropanol.
Sequencing and data analysis of benzonase-treated samples. DNA was
sequenced using either Illumina HiSeq2000 (TrueSeq V3 chemistry) or NextSeq500
(TrueSeq High output V2 chemistry) sequencers at the Advanced Technology
Research Facility, National Cancer Institute (NCI-Frederick, MD, USA). The
sequence reads were generated as either 50 or 75 mer (trimmed to 50 mer by
Trimmomatic software before alignment), and tags are then aligned to the UCSC
mm9 reference genome assembly using Eland or Bowtie2. All the samples were of
good quality with over 94% of the bases having Q30 or above with 25–50 million
raw reads per sample. Regions of enriched tags termed hotspots have been called
using DNase2Hotspots algorithm77 with an FDR of 0% with minor updates. Tag
density values were normalized to 10 million reads. For comparison of BACh
profiles across multiple cell lines, percent reference peak coverage (PRC) measure
was proposed and employed to ensure compatible levels of digestion by benzonase
in multiple cell lines78. To calibrate PRC, commonly represented hotspot sites were
identified as reference peaks based on the mouse (mm9) DNaseq data from
ENCODE. ENCODE narrowPeak definition files (DNaseI Hypersensitivity by
Digital DNaseI from ENCODE/University of Washington) for a total of 133 sam-
ples were downloaded from the UCSC golden path website: http://
hgdownload.cse.ucsc.edu/goldenPath/mm9/encodeDCC/wgEncodeUwDnase/. A
total of 8587 peaks were found to be present in all 133 samples. By assuming that
the most commonly accessible sites may also be present in our optimally digested
samples, PRC was obtained as a fraction of reference peaks presented in each
sample to evaluate the level of digestion by benzonase. Our pooled samples with a
PRC of 90% or greater indicated that all the 8587 sites were present in the sample.
Two biological replicates with acceptable PRC were selected and pooled for each
cell line, and each pooled dataset showed over 90% PRC. When samples showed
bimodality in their tag density distribution due to elevated noise, we dropped
hotspots that belonged to a group with low tag density and low PRC by applying a
threshold to maximum hotspot tag density values.
Computing environment. All computations at NCI were performed on the NIH
helix/biowulf system, documentation of which is available at https://helix.nih.gov.
We used the R computing environment, Perl scripts, Bedtools, and UCSC liftOver
for most of the analyses.
Identification of polymorphic BACh sites. The workflow consisted of the fol-
lowing: (1) the BACh data were filtered for the regions overlapping with poly-
morphic sites. Since the BACh data were generated in Genome Build mm9, we
used UCSC mm9 snp128 data to restrict the BACh sites. (2) Variant called format
files were filtered to retain the SNPs that overlap with the BACh present in the 4T1
and 4T07 cell lines. (3) SNPs were removed in the BACh that is present in the
mouse FVB/NJ strain.
Long read ChIA-PET sequencing and data processing. Long read ChIA-PET
was performed using Tn5 transposase to tag DNA for long tag sequencing by
Illumina NextSeq. ChIA-PET data was processed by a customized ChIA-PET data
processing pipeline22. A detailed protocol can be found in Li et al.79.
Cloning. A mouse Nup210 full-length complementary DNA (cDNA)
(NM_018815) encoding vector (pCMV6-Nup210-Myc) was purchased from Ori-
gene Technologies. This vector was digested with SalI-HF (New England Biolabs)
and EcoRV-HF (New England Biolabs) restriction enzymes to obtain the NUP210
protein-encoding region. This NUP210 insert was then cloned into the Gateway
entry vector pENTR1A using the Quick Ligation Kit (New England Biolabs).
pENTR1A no ccdB plasmid (Addgene plasmid # 17398) was received by Dr.
Marian Darkin (NCI) as a gift from Dr. Eric Campeau. The NUP210-encoding
region from the pCMV6-NUP210-Myc vector was cloned into pENTR1A vector
through digestion with SalI and EcoRV. pENTR1A-NUP210 entry vector was used
to transfer the NUP210-encoding region into the lentiviral destination vector
pDEST-658 (received as a gift from Dr. Dominic Esposito, NIH) along with a
mouse Pol2 promoter entry vector using the Gateway LR clonase reaction (Thermo
Fisher Scientific). The integrity of the final NUP210-encoding vector was verified
through DNA-sequencing.
The 3× Flag-histone H3.1 plasmid was received as a gift from Dr. Jing Huang
(NCI, NIH). The coding region of H3.1 along with Flag-Tag was amplified by PCR
using KOD Hot Start DNA Polymerase (Millipore) and cloned into gateway entry
vector pENTR/D-TOPO vector (Thermo Fisher Scientific). Entry vectors
containing Flag-H3.1 were then cloned into gateway lentiviral destination vector
pDest-659 (gift from Dr. Dominic Esposito Lab) along with mPol2 promoter and
C-terminal V5-tag entry vectors using the gateway LR clonase reaction (Thermo
Fisher Scientific).
The pGL4.23 [luc2/minP] promoter-luciferase vector (Promega, Catalog #
E8411) was received as a gift from Dr. Jing Huang (NCI, NIH). A 550 bp region
from the mouse (FVB/NJ and BALB/cJ) Nup210 promoter covering the
polymorphic sites was amplified by PCR using KOD Hot Start DNA Polymerase
(Millipore) and digested with KpnI (New England Biolabs) and XhoI (New England
Biolabs) restriction enzymes. Gel-purified PCR product was then cloned into the
pGL4.23 vector using T4 DNA ligase (New England Biolabs). Finally, the DNA
sequence of the clones was confirmed through DNA-sequencing.
pMXs-puro-EGFP-FAK plasmid was obtained as a gift from Dr. Noboru
Mizushima (University of Tokyo) (Addgene # 38194). cDNA encoding mouse FAK
(Ptk2) without EGFP was PCR amplified from this plasmid and subcloned into
pENTR/D-TOPO entry vector (Thermo Fisher Scientific). Entry vector is then
further cloned into lentiviral destination vector pDest-659 along with mPol2
promoter and C-terminal myc-tag entry vectors using the method described above.
cDNA encoding mouse Ccl2 was PCR amplified from 4T1 cells and subcloned into
pENTR/D-TOPO entry vector. Ccl2 entry vector is then further cloned into
lentiviral destination vector pDest-659 along with mPol2 promoter and C-terminal
myc-tag entry vectors using the above method. The sequence of the final clones
were confirmed through Sanger sequencing.
Lentivirus production and generation of stable cell lines. All of the TRC len-
tiviral shRNA vectors were purchased from Dharmacon. shRNAs targeting the
mouse Nup210 gene, sh-Nup # 1 (TRCN0000101935: TAACTATCACAGTAAG
AAGGC) and sh-Nup # 4 (TRCN0000101938: TTCAGTTGCTTATCTGTCAGC),
were used for Nup210 knockdown in all of the mouse cell lines. For mouse Ctcf
knockdown, sh-Ctcf # 1 (TRCN0000039022: TAAGGTGTGACATATCATCGG)
and sh-Ctcf # 2 (TRCN0000039023: ATCTTCGACCTGAATGATGGC) were
used. For mouse Ccl2 knockdown, sh-Ccl2 # 3 (TRCN0000034471:
TTACGGGTCAACTTCACATTC), sh-Ccl2 # 4 (TRCN0000034472:
TTGCTGGTGAATGAGTAGCAG), and sh-Ccl2 # 5 (TRCN0000034473:
AATGTATGTCTGGACCCATTC were used. For NUP210 knockdown in human
cell lines, an shRNA targeting the human NUP210 gene (TRCN0000156619:
AAATGAGCTAATGGGCAGAGC) was used.
For lentivirus production, shRNA-containing plasmids and packaging plasmids,
psPAX2 (Addgene plasmid # 12260) and envelope plasmid pMD2.G (Addgene
plasmid # 12259) (both were a gift from the Trono lab), were transfected into the
human 293FT (Thermo Fisher Scientific) cell line using X-tremeGENE 9 DNA
transfection reagent (Roche). At 48 h after transfection, culture supernatant
containing lentivirus was harvested, filtered through a 0.45 μm filter (Millipore),
and then used for transduction of mouse and human breast cancer cell lines.
shRNAs stably integrated into mouse and human cells were selected with 10 and
2 μg/ml puromycin (Sigma), respectively. For the selection of NUP210-
overexpressing cells, 10 μg/ml of blasticidin (Gibco) was used.
CRISPR/Cas9-mediated knockout of the mouse Nup210 gene. For CRISPR/
Cas9-mediated knockout of mouse Nup210 in the 4T1 cell line, single-guide RNA
(sgRNA) targeting Nup210 exon 5 (sgRNA sequence: GCGACACCATCCTAG
TGTCT) was designed using the GPP Web Portal available at the Broad Institute
(https://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-design). sgRNA
was then cloned into the lentiGuide-puro (Addgene plasmid # 52963, a gift from
the Feng Zhang lab) vector. Nontargeting control sgRNA cloned into the
lentiGuide-puro vector (sgRNA sequence: CCATATCGGGGCGAGACATG) was
kind of a gift from Dr. Ji Luo (NCI, NIH). Lentiviral particles were prepared as
described above for shRNA lentiviruses. 4T1 cells stably expressing the sgRNAs
were generated through lentiviral transduction and selection with 10 μg/ml pur-
omycin. For transient expression of Cas9 in the sgRNA-stable 4T1 cells, an ade-
noviral Cas9-encoding viral particle containing the GFP reporter (Vector Biolab)
was used at 25 MOI (multiplicity of infection) 96 h after transfection of the Cas9
vector, GFP-positive 4T1 cells were FACS sorted and single cells were isolated for
clonal expansion. Nup210 mutation was confirmed through DNA-sequencing and
knockout was verified through western blot. Before performing functional assays
with Nup210 KO cells, both sg-Ctrl and KO cells were passaged at least four times
for 2 weeks to eliminate residual Cas9-GFP signal within 4T1 cells, which was
verified using a fluorescence microscope.
CRISPR/Cas9 D10A-mediated deletion of CTCF-binding site on Nup210 pro-
moter. For the deletion of polymorphic CTCF-binding region on mouse Nup210
promoter, Cas9 D10A double-nicking strategy was used. Sense and antisense
sgRNAs spanning the CTCF-binding site were designed using the above link of the
GPP web portal of Broad Institute. All-in-One plasmid encoding dual U6
promoter-driven sgRNAs and EGFP-coupled Cas9 D10A plasmid (AIO-GFP) was
a gift from Dr. Steve Jackson (The Wellcome Trust Sanger Institute, UK) (Addgene
# 74119). sgRNAs were cloned into AIO-GFP plasmid using the method described
in the paper80. Briefly, the AIO-GFP plasmid was digested with BbsI restriction
enzyme, dephosphorylated using calf intestinal phosphatase, and gel purified.
sgRNA oligonucleotide pairs were purchased from Integrated DNA Technologies,
annealed, and phosphorylated using T4 polynucleotide kinase (NEB). First, sgRNA
was cloned into BbsI site, and second, sgRNA was cloned into BsaI site. The DNA
sequence of the final clone was verified via Sanger sequencing using the primer (5′-
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-27451-w ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:7216 | https://doi.org/10.1038/s41467-021-27451-w | www.nature.com/naturecommunications 17
CTTGATGTACTGCCAAGTGGGC-3′). sgRNA plasmid was then transfected into
4T1 cells using Nanojuice transfection reagent (Millipore). After 48 h, GFP-positive
cells were sorted using flow cytometry and single cells were plated on a 96-well
plate. Cas9 D10A-edited clones were identified using the PCR and DNA Sanger
sequencing.
Spontaneous metastasis assay in mice. Six- to eight-week-old female BALB/c
and FVB/NJ mice were purchased from The Jackson Laboratory. For orthotopic
transplantation of gene knockdown or overexpressing cells, 100,000 cells were
injected into the fourth mammary fat pad of mice. At 28–30 days after injection,
mice were euthanized and primary tumors were resected, weighed, and surface
lung metastases were counted. For all the mouse experiments, the ethics
committee-permitted maximum tumor size/burden was not exceeded.
Protein nucleocytoplasmic transport assay. 4T1 Nup210 knockdown cells were
grown on glass coverslips in a 2-well Lab-Tek chambered glass coverslip (Thermo
Fisher Scientific) at a seeding density of 20,000 cells per well. At 24 h after seeding,
cells were transfected with 1 μg of nucleocytoplasmic transport reporter (NLS-
tdTomato-NES) plasmid (received as a gift from Dr. Martin W. Hetzer, Salk
Institute) using Novagen Nanojuice Transfection Reagent (Millipore-Sigma). At
4 h after transfection, the medium was replaced with a fresh medium and cells were
grown for 24 h. Cells were then treated with 20 nM leptomycin B (Cell Signaling
Technology) for 6 h and then fixed with methanol for immunostaining with an
antibody against NPC proteins (clone mAb414, Abcam) following the regular
immunofluorescence protocol described below. Nuclear and cytoplasmic expres-
sion of tdTomato was observed using confocal microscopy.
Protein interaction analysis through liquid chromatography-mass spectro-
metry (LC-MS). NUP210-Myc-overexpressing 4T1 cells were seeded onto 15 cm
tissue culture dishes at a seeding density of 2.5 × 106 cells per dish. After 48 h of
incubation, cells were harvested and nuclear protein complex lysates were prepared
using the Nuclear Complex Co-IP Kit (Active Motif). Co-IP with two biological
replicates was performed according to the manufacturer’s instructions. Briefly,
500 μg of nuclear protein lysates were incubated with 2 μg of either Myc-Tag
antibody (Cell Signaling Technology) or an endogenous NUP210-specific antibody
(Bethyl Laboratories). After overnight incubation on a rotator at 4 °C, 25 μg of
Dynabeads Protein G (Invitrogen) were added to the protein lysate–antibody
complexes. After 30 min of incubation with beads, antibody–bead–protein com-
plexes were isolated using a magnetic stand. Beads were then washed three times
and then dissolved in 25 mM ammonium bicarbonate pH 8.0 (Sigma). Samples
were then subjected to LC-MS analysis.
Western blot. Whole-cell protein lysate was prepared using lysis buffer (20 mM
Tris-HCl pH 8.0, 400 mM NaCl, 5 mM EDTA, 1 mM EGTA, 10 mM NaF, 1 mM
sodium pyrophosphate, 1% Triton X-100, 10% glycerol, protease and phosphatase
inhibitor cocktail). Nuclear and cytoplasmic protein lysates were prepared using
the Nuclear Extract Kit (Active Motif) or Nuclear Complex Co-IP Kit (Active
Motif). Protein concentration was measured using the Pierce BCA Protein Assay
Kit (Thermo Fisher Scientific). Twenty-five micrograms of protein lysates was
mixed with 4× NuPAGE LDS sample buffer (Invitrogen) and 10× NuPAGE Sample
Reducing Agent (Invitrogen). Samples were then boiled at 95 °C for 5 min and
resolved on NuPAGE 3–8% Tris-acetate, NuPAGE 4–12% Bis-Tris, or Novex
4–20% Tris-glycine protein gels (Thermo Fisher Scientific) with appropriate run-
ning buffer. Protein was transferred onto a PVDF membrane (Millipore) and the
membrane was blocked with blocking buffer (TBST+ 5% non-fat dry milk) for 1 h.
Membranes were then incubated with appropriate primary antibodies overnight.
After washing with TBST, membranes were incubated with secondary antibodies
for 1 h. Finally, the signal was developed on X-ray film using the Amersham ECL
Western Blotting Detection Reagent (GE Healthcare). Densitometry quantification
of western blot was performed using the FIJI software81.
Primary antibodies and their dilutions were as follows: NUP210 (1:500; Bethyl
Laboratories), β-actin (1:10,000; Abcam), Lamin B1 (1:5000; Abcam), Lamin A/C
(1:1000; Abcam), Myc-Tag (1:1000; Cell Signaling Technology), rabbit V5-Tag
(1:1000; Cell Signaling Technology), mouse V5-Tag (1:1000; Cell Signaling
Technology), RRP1B (1:1000; Millipore-Sigma), SUN1 (1:500; Abcam), SUN2
(1:1000; Abcam), FAK (1:5000; Abcam), p-FAK(Y397) (1:5000; Abcam), p-FAK
(Y397) (1:5000; Thermo Fisher Scientific), CCL2 (1:1000; Proteintech), H3.1/3.2
(1:1000; Active Motif), H3K27me3 (1:5000; Cell Signaling Technology), H3K9me3
(1:5000; Abcam), SUV39H1 (1:1000, Cell Signaling Technology), EZH2 (1:1000;
Cell Signaling Technology), and SUZ12 (1:1000; Cell Signaling Technology). Anti-
mouse horse radish peroxidase (HRP) secondary antibody (GE Healthcare) was
used at 1:10,000 dilution and anti-rabbit HRP secondary antibody (Cell Signaling
Technology) was used at 1:3000 dilution.
Coimmunoprecipitation. Co-immunoprecipitiation was performed using the
Nuclear Complex Co-IP Kit (Active Motif). 4T1 cells were seeded onto 15 cm tissue
culture dishes at a seeding density of 5 × 106 cells per dish. After 48 h of incubation,
cells were harvested and nuclear lysates were prepared. A total of 200–500 μg of
nuclear lysates were incubated with 2 μg of specific antibodies and 50 μg of
Dynabeads Protein G (Invitrogen). After overnight incubation on a rotator at 4 °C,
immune complexes were isolated using a magnetic stand. Beads were then washed
three times, resuspended in 2× NuPAGE LDS sample buffer (Invitrogen), and
incubated at 95 °C heat block for 5 min. Samples were loaded onto NuPAGE
protein gels and the standard western blot protocol was followed as
described above.
For co-IP in 293FT cells, 2.5 × 106 cells were seeded into 15 cm tissue culture
dishes. Flag-H3.1 (5 μg) and NUP210-Myc (5 μg) plasmids were cotransfected
using X-tremeGENE 9 transfection reagent. At 48 h after transfection, cells were
harvested and nuclear protein lysates were prepared using the Nuclear Complex
Co-IP Kit (Active motif). Co-IP was followed as described above.
Immunofluorescence and confocal microscopy. Immunofluorescence analysis
was performed as described previously28. Briefly, cells were grown on 4- or 8-well
polymer coverslips (Ibidi) at a seeding density of 40,000 or 20,000 cells per well,
respectively. After 24 h of incubation, cells were fixed with −20 °C methanol for
2 min and permeabilized with phosphate-buffered saline (PBS) containing 1%
Triton X-100 for 1 min. Fixed cells were then blocked with immunofluorescence
buffer (1× PBS, 10 mg/ml bovine serum albumin (BSA), 0.02% SDS, and 0.1%
Triton X-100) for 30 min. Cells were then incubated with primary antibodies
diluted in immunofluorescence buffer overnight at 4 °C. After washing the cells
with immunofluorescence buffer three times for 10 min per wash, cells were
incubated with Alexa Fluor-conjugated secondary antibodies for 1 h at room
temperature. Cells were washed three times with immunofluorescence buffer and
then incubated with 1 μg/ml DAPI for 10 min to stain the nucleus. After washing
the cells with PBS three times, slides were kept at 4 °C until subjected to confocal
microscopy. In cases of drug treatment followed by super-resolution microscopy,
cells were treated with 1 μM JQ1, 5 μM GSKJ4, and 0.5 μM CytoD for 24 h. Images
were acquired using either a Zeiss LSM 780 confocal microscope (×63 plan-
apochromat NA 1.4 oil-immersion objective lens, 0.09 μm X–Y pixel size and
1.0 μm optical slice thickness), a Zeiss LSM 880 Airyscan super-resolution
microscope (Airyscan detector, ×63 plan-apochromat NA 1.4 oil-immersion
objective lens and 0.05 μm X–Y pixel size), a Zeiss LSM 780 Elyra with SIM module
or a Nikon SoRa spinning disk super-resolution microscope (Yokogawa SoRa
spinning disk unit, ×60 plan-apochromat NA 1.49 oil-immersion objective lens,
Photometrics BSI sCMOS camera, and 0.027 μm X–Y pixel size). Airyscan images
were processed using the Airyscan processing algorithm in the Zeiss ZEN Black
(v.2.3) software, whereas the Nikon SoRa images were deconvolved using a con-
strained iterative restoration algorithm in the Nikon NIS Elements (v5.11) soft-
ware. Tetraspeck 0.2 μm beads (Invitrogen) were imaged with the same microscope
parameters and used for channel alignment. Further image processing was done in
Zeiss ZEN Blue V2 software.
Primary antibodies used for immunofluorescence were as follows: p-FAK
(Y397) (1:100; Abcam), H3.1/3.2 (1:1000; Active Motif), mouse Myc-Tag (1:500;
Cell Signaling Technology), rabbit Myc-Tag (1:100; Cell Signaling Technology),
SUN1 (1:100; Abcam), SUN2 (1:100; Millipore), p-MLC2-S19 (1:100; Cell
Signaling Technology), p-FAK Y397 (1:500 for tissue IF; Thermo Fisher Scientific),
H3K4me3 (1:1000; Millipore), rabbit H3K27me3 (1:1000; Cell Signaling
Technology), mouse H3K27me3 (1:250; Abcam), H3K27Ac (1:500; Cell Signaling
Technology), H3K9me3 (1:1000; Abcam), Nucleolin (1:500; Abcam), Lamin B1
(1:500; Abcam), Lamin A/C (1:500; Abcam), and NPC antibody (clone mAb414,
1:1000; Abcam). Secondary antibodies used were mouse Alexa Fluor 488 (1:200;
Invitrogen), Phalloidin Alexa Fluor 488 (1:250; Invitrogen), rabbit Alexa Fluor 488
(1:200; Invitrogen), rabbit Alexa Fluor 568 (1:200; Invitrogen), rabbit Alexa Fluor
594 (1:200; Invitrogen), and mouse Alexa Fluor 594 (1:200).
Immunofluorescence on tumor tissue. Frozen tumor tissue sections were fixed in
4% paraformaldehyde in PBS for 10 min at room temperature. Slides were then
washed with PBS three times and permeabilized with 0.5% Triton X-100 in PBS for
3 min. After washing with 1× PBS three times, slides were then incubated with a
blocking solution (10% BSA in PBS) for 1 h. Primary antibodies were diluted in
blocking solution, added to the tissue sections, and incubated overnight at 4 °C.
Slides were washed three times with PBS+ 0.1% Tween-20 (PBST) for 5 min and
incubated with secondary antibodies in blocking buffer for 1 h at room tempera-
ture. Sections were then washed with 1× PBST three times for 5 min and incubated
with DAPI solution (1 μg/ml) for 10 min at room temperature. Slides were washed
with 1× PBS three times for 5 min and then mounted with Prolong Glass Antifade
mountant (Invitrogen). Confocal Z-stack images were acquired using Nikon SoRA
spinning disk microscope. Dilution of the primary antibodies are as follows: rabbit
p-FAK Y397 (1:500; Thermo Fisher Scientific), mouse Alexa Fluor 488-conjugated
pan-cytokeratin (1:100; Cell Signaling Technology). Dilution of the secondary
antibodies are as follows: anti-rabbit Alexa Fluor 568 antibody (1:200; Invitrogen).
FRAP assay. 4T1 cells were grown on 35 mm glass-bottom dishes (MatTek). After
overnight incubation, cells were transfected with 0.5 μg POM121-GFP plasmid
(Genecopoeia) using Nanojuice transfection reagent. At 24 h after transfection,
cells were subjected to FRAP analysis in Zeiss 880 confocal microscope. The
percent mobile fraction of POM121-GFP in each condition was calculated using
the FRAP module fit formula option of the ZEN software (Zeiss).
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Cell cycle analysis. Cell cycle analysis was performed using the Click-iT EdU (5-
ethynyl-2′-deoxyuridine) Alexa Fluor 488 Flow Cytometry Assay Kit (Thermo
Fisher Scientific) and FxCycle Violet Stain (Thermo Fisher Scientific) according to
the manufacturer’s instructions. Briefly, 4T1 cells were seeded onto 15 cm tissue
culture dishes at a seeding density of 3 × 106 cells per dish. After 24 h, cells were
pulsed with Click-iT EdU for 1 h. After harvesting the cells through trypsinization,
cells were fixed with Click-iT fixative and permeabilized with a saponin-based
permeabilization agent. The Click-iT reaction was then performed for 30 min at
room temperature. Cells were then washed with wash buffer and stained for DNA
content analysis with FxCycle Violet, a DNA-selective dye. Finally, cell cycle
analysis was performed using a BD FACSCanto II flow cytometer (BD Bioscience).
Data were analyzed using the FlowJo V10 (FlowJo, LLC) software.
ChIP-seq analysis. ChIP was carried out using the ChIP-IT Express Enzymatic
Chromatin Immunoprecipitation Kit (Active Motif) according to the manu-
facturer’s instructions. Briefly, 5 × 106 4T1 cells were seeded onto 15 cm tissue
culture dishes. After 48 h of incubation, cells were fixed with 1% formaldehyde for
10 min at room temperature. Cells were washed with ice-cold PBS and for-
maldehyde cross-linking was quenched using glycine stop-fix solution. Cells were
harvested through scraping and pelleted by centrifugation at 2500 r.p.m. for 10 min
at 4 °C. After cell lysis with ice-cold lysis buffer and a Dounce homogenizer,
chromatin was sheared using an enzymatic shearing cocktail for 12 min at 37 °C.
The shearing reaction was stopped with 0.5 M EDTA and the chromatin was
separated through centrifugation at 15,000 r.p.m. for 10 min at 4 °C. Sixty to
seventy micrograms of chromatin was used with 25 μl of Protein G magnetic beads
and 2 μg of specific antibodies for each ChIP reaction. The following antibodies
were used for the ChIP reactions: anti-rabbit NUP210 (Bethyl Laboratories), anti-
rabbit H3K27me3 (Cell Signaling Technology), anti-rabbit H3K4me3 (Millipore),
and anti-mouse NPC antibody (clone mAb414, Abcam). After incubating the
reaction mixture overnight at 4 °C on a rotator, the beads were washed with ChIP
buffers and DNA was eluted with elution buffer. DNA was then reverse-cross
linked, proteinase K-treated, and DNA quality was assessed using an Agilent
Bioanalyzer before ChIP-seq library preparation. The library was prepared using a
TruSeq ChIP Library Preparation Kit (Illumina) and pooled samples were
sequenced on the NextSeq platform.
ChIP-seq data were analyzed using the Sicer algorithm82 with default
parameters. For narrow peaks such as H3K4me3 enrichment, a window size of 200
was used. For broad peaks such as H3K27me3 and NUP210, a window size of 1000
was used. The ChIP-seq plot profile was generated using deepTools283. For ChIP-
seq peak annotation, the ChIPSeeker84 Bioconductor package was used. BigWig
files were displayed using the Integrative Genomics Viewer85.
Publicly available ChIP-seq and Hi-C data analysis. H3K27Ac ChIP-seq data
from mouse mammary luminal cells were downloaded from Gene Expression
Omnibus (GEO) (accession no.: GSE116384)26. CTCF ChIP-seq data from mouse
mammary epithelial cells were obtained from GEO (accession no.: GSE92587,
sample: GSM2433042)20. CTCF and H3K27Ac ChIP-seq data from the MCF7
human breast cancer cell line were obtained from GEO (accession no.:
GSE130852). Publicly available Hi-C data from mESCs were derived from Bonev
et al.37 and displayed using the 3D-Genome Browser38.
RNA isolation and quantitative reverse transcriptase real-time PCR (qRT-
PCR). Cells were directly lysed on cell cultures plate with 1 ml TriPure Isolation
Reagent (Sigma). After adding 200 μl chloroform and centrifuging at 14,000 r.p.m.
for 15 min at 4 °C, the upper aqueous layer containing the RNA was transferred to
a new tube. To precipitate RNA, 500 μl of isopropanol was added to each tube,
which was then vortexed and incubated at −20 °C for 1 h. The RNA was further
purified using the RNeasy Mini Kit (Qiagen) with on-column DNase (Qiagen)
digestion according to the manufacturer’s instructions. Two micrograms of total
RNA was used for cDNA preparation using the iScript cDNA Synthesis Kit (Bio-
Rad). A 1/10 dilution of cDNA was used for qRT-PCR analysis using the FastStart
Universal SYBR Green Master Mix (Roche). Sequences of the primers used are
listed in Supplementary Table 1.
ChIP qPCR analysis. Chromatin was isolated from 4T1 and 6DT1 cells using the
ChIP-IT Express Enzymatic Kit (Active Motif) according to the manufacturer’s
instructions as mentioned above. Ten microliters of normal rabbit IgG (Cell Sig-
naling Technology), 10 μl of rabbit CTCF (Cell Signaling Technology), and 10 μl of
rabbit H3K27Ac (Cell Signaling Technology) antibodies were used for the
immunoprecipitation reaction. ChIP DNA was then subjected to qPCR analysis.
The percent (%) input method was used for the calculation of CTCF and H3K27Ac
enrichment.
RNA-seq analysis. 4T1 cells were seeded onto 6 cm tissue culture dishes at a
seeding density of 4 × 105 cells per dish. After 48 h of incubation, total RNA was
isolated using the protocol described above. On-column DNase treatment was
performed to eliminate DNA contamination. Library preparation was performed
using the TruSeq Stranded mRNA Library Prep Kit (Illumina) and pooled samples
were sequenced on a HiSeq2500 with TruSeq V4 chemistry (Illumina). Differential
gene expression analysis from RNA-seq data was performed using the Partek Flow
software. GO enrichment analysis of differentially expressed genes was performed
using the PANTHER classification system86.
Promoter-luciferase assay. The 24-well tissue culture plates were coated over-
night with 100 μg/ml type I collagen. 293FT cells were seeded in an antibiotic-free
medium at a seeding density of 75,000 cells per well of 24-well plate. Two hundred
and fifty nanograms of pGL4.23 Nup210 luciferase promoter vectors and 25 ng of
pRL-TK Renilla luciferase vectors were cotransfected using NanoJuice transfection
reagent (Millipore). At 24 h after transfection, the luciferase assay was performed
using Dual-Luciferase Reporter Assay System Kit (Promega) according to the
manufacturer’s instructions. Luciferase activity was measured using a GloMax 96
Microplate Luminometer (Promega). Firefly luciferase activity was normalized with
Renilla luciferase activity. Eight biological replicates were used per condition.
Cytokine array. 4T1 Nup210 knockdown cells were cultured in low serum con-
dition (1% FBS) in 6-well plates at a seeding density of 500,000 cells per well. At
24 h after incubation, cell culture supernatants were harvested and centrifuged to
remove the dead cells. One milliliter of supernatant was used for cytokine profiling
using the Proteome Profiler Mouse XL Cytokine Array (R & D Biosystems)
according to the manufacturer’s instructions. Chemiluminescent signals were
quantified using the ImageJ (NIH) software.
3D-DNA FISH analysis. For DNA FISH analysis, cells were grown on Lab-Tek
chamber slides. Cells were briefly washed with PBS and fixed with 4% paraf-
ormaldehyde. Cells were permeabilized with 0.2% Triton X-100 in PBS and then
hybridized with a labeled probe. For probe generation, BAC clones were purchased
from CHORI (https://bacpacresources.org/). The following BAC clones were used
for the experiment: Cxcl region: clone RP23-374O6; Postn region: clone RP23-
480C1; Ccl2 region: clone RP23-99N1, and Itgb2 region: clone RP23-166E21. All
the clones were expanded and DNA was isolated using the FosmidMax DNA
Purification Kit (Epicentre). DNA from each clone was labeled through nick
translation with either the Atto550 NT Labeling Kit (Jena Bioscience) or the
Digoxigenin NT Labeling Kit (Jena Bioscience). Hybridization was carried out in a
humidified chamber at 37 °C for 16 h. Post-hybridization rapid wash was carried
out with 0.4× SSC at 72 °C for 4 min. Digoxigenin was detected with a DyLight
594-Labeled Anti-Digoxigenin/Digoxin (DIG) antibody (Vector Laboratories). The
slides were stained with DAPI and Z-stack images were captured using a Zeiss LSM
880 Airyscan microscope.
Response to ECM stiffness assay. To test the ECM stiffness effect on tumor cells,
polyacrylamide hydrogel-bound cell culture plates with different elastic moduli was
used as a mimic of ECM stiffness. 6-well plates with 0.2 kPa (soft) or 12 kPa (stiff)
elastic moduli were purchased from Matrigen. Each well of the plate was coated
with 20 μg/ml fibronectin (Sigma) in PBS for 1 h at 37 °C. After washing the well
with PBS, 4T1 cells were seeded on top of the soft or stiff matrix at a seeding
density of 100,000 cells per well. At 48 h after incubation, cells were harvested for
RNA or protein isolation.
Focal adhesion and cell spreading assay. For focal adhesion immunostaining,
Lab-Tek 2-well glass chamber slides (Thermo Fisher Scientific) were coated with
50 μg/ml of collagen type I (Gibco) or 20 μg/ml fibronectin. Cells were seeded at a
seeding density of 20,000–50,000 cells per well. After 6 h or overnight incubation,
cells were fixed in 4% paraformaldehyde for 20 min. Cells were then washed with
PBS, permeabilized with PBS+ 0.1% Triton X-100 for 5 min, and blocked with
PBS+ 5% normal goat serum. Cells were incubated with phospho-FAK (Y397)
antibody for 1 h. After washing with PBS, cells were incubated with Alexa Fluor
594-conjugated rabbit secondary antibody and Alexa Fluor 488-conjugated phal-
loidin (F-actin staining) for 1 h. The slides were then washed with PBS and
mounted using DAPI (1 μg/ml) or VECTASHIELD with DAPI Mounting Medium
(Vector Laboratories). Images were captured using a Zeiss 780/880 confocal
microscope.
To check the effect of recombinant CCL2 on cell spreading of Nup210 KO cells,
50,000 4T1 sg-Ctrl and Nup210 KO cells were seeded onto Lab-Tek glass coverslip
coated with type I collagen (50 μg/ml). Cells were allowed to attach on a coverslip
for 1 h and then cells were incubated with murine recombinant CCL2 (Peprotech)
for 5 h. Images were captured using a brightfield microscope and cell area was
quantified using ImageJ (NIH) software.
Actin polymerization inhibition using cytochalasin D. For the cytochalasin D
treatment of 4T1 Nup210 knockdown cells, 20,000 cells were seeded onto 4-well μ-
Slides with polymer coverslips (Ibidi). After 24 h, cells were treated with 1 μM
CytoD, a potent inhibitor actin polymerization, for 2 h. After the treatment, cells
were washed with complete medium three times and incubated for another 2 h in a
37 °C CO2 incubator for the recovery of actin polymerization. Cells were then fixed
with 4% paraformaldehyde for 30 min and stained with Alexa Fluor 488-
conjugated phalloidin for immunofluorescence imaging. Nuclei were stained with
1 μg/ml Hoechst 33342 (Thermo Fisher).
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For the western blot assay, 2.5 × 106 4T1 cells were seeded onto 15 cm cell
culture dishes. After 24 h, cells were treated with 0.5 μM CytoD and incubated 24 h
before harvesting the cells for protein isolation. For RNA isolation, 3 × 105 cells
were seeded onto 6 cm dishes. After 24 h later, cells were treated with 0.5 μM
CytoD and incubated 24 h before lysing the cells for RNA isolation.
Histone-modifying enzyme inhibitor treatment. For immunofluorescence
microscopy, 4T1 sg-Ctrl and Nup210 KO cells were seeded onto 4-well μ-Slides at a
seeding density of 25,000 cells per well. After 24 h, cells were treated with dimethyl
sulfoxide, 5 μM EZH2 inhibitor GSK126 (Selleckchem), or 5 μM H3K27me3
demethylase inhibitor GSKJ4 (Selleckchem) for another 24 h. Cells were then fixed
with −20 °C methanol for 2 min. Histone H3.1/3.2 and H3K27me3 antibodies were
used for immunofluorescence staining according to the protocol described above28.
For the qRT-PCR analysis, 2 × 105 4T1 Nup210 KO cells were seeded onto 6 cm
dishes. After 24 h, 5 μM GSK126 or 5 μM GSKJ4 was applied to the cells that were
then incubated for another 24–48 h. Cells were then lysed, RNA was isolated, and
qRT-PCR was performed as described above.
Live-cell imaging assay. For the automated random cell migration assay, 4T1 cells
were seeded onto 96-well polystyrene microplates (Corning) at a seeding density of
2000 cells per well so that the cell density remained subconfluent until the end of
the imaging period. After 24 h of incubation, cells were incubated with a complete
medium containing 200 ng/ml Hoechst 33342 (Thermo Fisher Scientific) for 1 h.
Cells were then transferred to a Nikon Eclipse Ti2 microscope. Images were cap-
tured every 12 min with a 20 × 0.8 NA objective for 24 h. Total light exposure time
was kept to 200 ms for each time point. Cells were imaged in a humidified 37 °C
incubator with 5% CO2. Image processing and cell tracking were carried out with a
custom MATLAB script described previously87. Live-cell imaging of nuclear size
was also performed using the same approach. To observe the effect of GSK126 and
JQ1 drugs on nuclear size, 3000 cells were seeded onto Ibidi 96-well polymer
coverslip plates. After 24 h, cells were stained with Hoechst 33342 for 45 min,
washed the medium three times with PBS, and cells were treated with either 5 μM
GSK126 or 1 μM JQ1 and imaged for 24 h.
To study the actomyosin tension dynamics of NUP210-depleted cells, F-tractin-
mRuby-P2A-mTurquoise-MLC2 reporter43, a gift from Dr. Tobias Meyer of
Stanford University (Addgene # 85146), was used. 6DT1 cells were transduced with
this reporter and 50,000 cells were seeded onto type I collagen (50 μg/ml) coated
Ibidi 4-well glass-bottom coverslip. After 24 h, cells were imaged with a Zeiss 880
Airyscan microscope for 1 h (images were taken at every 15 min). Cells were then
treated with 1 μM CytoD for 1 h and imaged. After the drug washout, cells were
then further imaged (every 15 min) for 15 h in a humidified 37 °C incubator with
5% CO2.
Cell invasion assay. The cell invasion assay was performed using BioCoat Matrigel
Invasion Chambers with 8.0 µm PET Membrane (Corning) according to the
manufacturer’s instructions. Briefly, 7.5 × 105 4T1 and 6DT1 cells were seeded onto
the top well containing DMEM with 0.5% serum. In the bottom well, DMEM with
10% serum was used as a chemoattractant. Cells were incubated in a 37 °C incu-
bator for 24 and 48 h for 6DT1 and 4T1 cells, respectively. After incubation,
noninvaded cells were removed from the top well using cotton tips. Cells that had
invaded into the Matrigel were then fixed with methanol and stained with 0.05%
crystal violet. Matrigel membranes containing invaded cells were then cut and
mounted onto glass slides with Vectashield mounting medium (Vector Labora-
tories). Images of entire membranes were captured as segments and then stitched
using an EVOS FL Auto 2 microscope (Invitrogen). Image analysis was performed
using the Image-Pro Premier 3D (Media Cybernetics) software. Percent cell
invasion was calculated using crystal violet intensity per membrane area.
CTC analysis. One hundred thousand 6DT1 cells with or without Nup210
knockdown were injected into the fourth mammary fat pad of FVB/NJ mice. Ten
mice were used in each group and three mice were kept uninjected for use as
healthy controls. One month after injection, mice were anesthetized with avertin
injection. Through cardiac puncture, 600–1000 μl blood per mouse was collected in
50 μl of 0.5 M EDTA solution. An equal volume of blood was taken for red blood
cell lysis using ACK lysis buffer. One hundred microliters of the peripheral blood
lymphocyte fraction was subjected to fixation with 2% paraformaldehyde for
15 min at room temperature. Cells were permeabilized with PBS containing 0.1%
Triton X-100. Cells were vortexed briefly and kept at room temperature for 30 min.
BSA (0.5%) in PBS was added and cells were pelleted by centrifugation. Cells were
then resuspended in ice-cold 50% methanol in PBS and incubated for 10 min on
ice. One hundred and fifty thousand fixed cells were stained for CD45, a pan-
lymphocyte marker, and pan-keratin, a tumor cell marker. Before staining with
antibodies, cells were incubated with a FcR blocking reagent (1:10 dilution; Mil-
tenyi) for 10 min at 4 °C. Cells were then stained with APC-conjugated CD45 (1:25
dilution; Miltenyi) and Alexa Fluor 488-conjugated pan-keratin (1:25 dilution, Cell
Signaling Technology) antibodies for 10 min at 4 °C. Appropriate isotype control
antibodies (Alexa Fluor 488-conjugated mouse IgG1 and APC-conjugated rat
IgG2b, k-isotype control) were used along with the primary antibodies. After
washing with MACS buffer (PBS, 0.5% BSA, and 2 mM EDTA), cells were
incubated with 1 μg/ml Hoechst 33342 (Thermo Fisher Scientific) for 5 min. Cells
were then washed again with MACS buffer and resuspended in 200 μl buffer for
analysis using a BD FACSCanto II flow cytometer. A CTC (CD45−/cytokeratin+)
gate was created based on the staining pattern of 6DT1 tumor cells in culture and
primary tumor cells derived from 6DT1-injected mice. Flow cytometry data were
analyzed using the FlowJo V10 software.
Immunohistochemistry analysis. Normal human mammary gland tissue section
(HuFPT127) and human breast cancer TMA slide (BR10010e) were purchased
from US Biomax Inc. (Rockville). Formalin-fixed, paraffin-embedded TMA slides
were processed for antigen retrieval for 15 min performed using TAR buffer pH 6
(Dako) in a steamer. Slides were washed followed by endogenous peroxidase (3%
hydrogen peroxide in methanol) for 20 min. Protein blocking was performed for
20 min (Dako). NUP210 primary antibody (Atlas) was applied at a dilution of
1:100 in antibody diluent (Dako) for 1 h at room temperature. After incubation,
slides were washed in TBS-tween, and Evision+System-HRP-labeled polymer anti-
rabbit (Dako) was applied for 30 min at room temperature. Next, slides were
washed in TBST, then the signal was developed using 3,3′-diaminobenzidine tet-
rahydrochloride as the chromogen substrate (Vector Lab). Slides were counter-
stained with hematoxylin. A digital image data file was created for the TMA slide
by optically scanning with the Aperio AT2 scanner (Leica Biosystems) at 0.25 μm/
pixel resolution (×40 objective). HALO (Indica Labs) Artificial Intelligence (AI)
neural network software (mini-net, Indica) was utilized to produce a classification
algorithm for tumor and stroma area segmentation and quantification. To quantify
the NUP210 signal (pixels) in the nuclear envelope of AI-classified tumor cells
based upon color and constant image intensity thresholding, a second algorithm
was created using HALO Area Quantification to deconvolve colocalization of DAB
chromogen and hematoxylin. Once established, the parameters for image proces-
sing were held constant across the experiment. Derived labeling ratios were indices
produced by dividing immunolabeled areas of nuclear envelope by tumor area
(×100).
Patient datasets analysis. DMFS analysis on gene expression signature was
performed using GOBO tool (http://co.bmc.lu.se/gobo/gobo.pl)88. Data on
NUP210 and histone H3.1 (HIST1H3A, HIST1H3B) amplification in human breast
cancer patients were derived from METABRIC data available on cBioPortal
(https://www.cbioportal.org/)89. METABRIC NUP210 mRNA expression data were
also downloaded from the cBioPortal database and manually processed for further
analysis. DMFS data (NUP210 mRNA) were obtained from the Km-plotter data-
base (https://kmplot.com/analysis/). The JetSet best probe 213947_s_at was used
for NUP210 expression and patients were separated by upper and lower quartile
values. Distant metastasis-free survival data (NUP210 protein) were obtained from
Km-plotter database protein module. NUP210 gene expression data on breast
cancer metastatic sites, prostate cancer, and melanoma were downloaded
from GEO.
Statistics and reproducibility. Experiments have been repeated at least duplicate
or triplicates except for studies involving mice (metastasis assay) where the
experiment was carried out once for each orthotopic transplantation models to
limit the use of animals. Three different immunocompetent orthotopic trans-
plantation models of metastasis and two different mice backgrounds were used to
validate the robustness of key results in different biological systems. For in vivo
animal studies, p values were calculated using the Mann–Whitney U test for
comparison of two groups in the GraphPad Prism 8 software and the results were
reported as mean ± standard deviation. For comparison of more than two groups,
analysis of variance (ANOVA) with appropriate multiple comparison tests were
performed in GraphPad Prism software. For microscopy image quantification
analysis, either Mann–Whitney U test (comparison of two groups) or ANOVA
with appropriate multiple comparison tests (comparison of multiple groups) were
performed. For qRT-PCR result analysis, p values were calculated using a multiple
two-tailed, unpaired t test in GraphPad Prism and results were reported as
mean ± standard error of the mean (s.e.m).
Microscopy image analysis and quantification. The periphery/total nuclear area
intensity ratio of histone H3.1/3.2, H3K27me3, and H3K9me3 was quantified using
the Fiji software81. Briefly, the total nuclear area was defined by DAPI staining,
while the nuclear periphery was defined as the region 25% towards the interior
from the nuclear edge (average distance for sg-Ctrl: 0.97 μm and KO-N13:
0.89 μm). Mean fluorescence intensity was quantified in both the periphery and
total nuclear area and the periphery/total ratio was plotted. The heterochromatic
foci/total nuclear area intensity of histone H3.1/3.2 was quantified using the Fiji
software. Heterochromatic foci regions were segmented using DAPI staining. Mean
fluorescence intensity was quantified in both heterochromatic foci and total nuclear
area and the heterochromatic foci/total ratio was plotted as box plots (bottom and
top of the box denote first and third quartile, respectively, whiskers denote ±1.5
interquartile range (IQR), horizontal lines denote median values). P values were
calculated using a two-tailed Mann–Whitney U test.
The position of DNA FISH spots relative to the nuclear centroid and periphery
was quantified using the Cell module within the Imaris image analysis suite
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(Bitplane). To account for differences in nuclear size, the relative position was
calculated by dividing the shortest distance of the FISH spot to the nuclear
centroid, by the length of the three-point line encompassing the nuclear centroid,
FISH spot, and nuclear periphery. Relative positions were plotted as cumulative
distribution frequencies using the RStudio software. P values were calculated using
a two-tailed Mann–Whitney U test. The distance of DNA FISH spots to
heterochromatic foci was quantified using the Fiji software with the 3D region of
interest manager plugin, TANGO90. Heterochromatic foci were segmented using
DAPI staining and used to create a distance map. DNA FISH spots were segmented
and the distance to the nearest heterochromatic foci was calculated and plotted as
box plots (bottom and top of the box denote first and the third quartile,
respectively, whiskers denote ±1.5 IQR, horizontal lines denote median values). P
values were calculated using a two-tailed Mann–Whitney U test.
Focal adhesion counts per cell were quantified using the Fiji software.
Cytoplasmic areas were segmented using phalloidin staining. p-FAK Y397 stained
focal adhesions were segmented as follows. Adhesions were filtered from image
noise using a difference of Gaussian band-pass filter. The filtered image was
subsequently segmented using an intensity threshold. Segmented adhesions were
counted and quantified on a per-cell basis.
Three-dimensional surface reconstruction of Z-stack images has been
performed using Imaris image analysis suite version 9.7.1 (Bitplane).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Gene expression (RNA-seq) and ChIP-seq data generated in this study have been
deposited in Gene Expression Omnibus (GEO) database under the accession number
GSE146591. All the Source data underlying Figures, Supplementary figures, and
uncropped western blot images are provided as a Source data file. Supplementary Movie
files (1–11) are provided as additional Supplementary Data files. All the other data are
available within the article and its Supplementary information. A reporting summary of
this article is available as a Supplementary information file. Source data are provided with
this paper.
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